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Such understated power here, in these tottering dancers who exert stupendous effort on 
tasks most view as insignificant. Such quiet beauty here, in these, my soft-voiced, stiff-
limbed people; such resolve masked by each placid face. There is immensity required in 
growing small, so bent on such unbending grace. 
 
From the poem No Signs of Struggle 







The overall aim of this thesis was to explore perceptions and performance of balance 
and gait in people with Parkinson’s disease (PwPD), and to evaluate both the current 
evidence for exercise-induced neuroplasticity and the feasibility of investigating 
exercise-induced neuroplastic changes among PwPD. 
This thesis includes four papers of different designs; a qualitative interview study (paper 
I), a systematic review and meta-analysis (paper II), a pilot RCT (paper III) and a cross-
sectional study (paper IV). Participants in papers I, III & IV were recruited through 
advertisement in newspapers and through the Parkinson association in Stockholm 
(sample sizes n=18, n=13 and n=93, respectively), whereas paper II selected studies from 
database searches (included studies n=13, total participant sample n=213). 
Five themes emerged from the qualitative content analysis of the interviews, the 
underlying patterns of which formed the overarching theme  “Focus and determination 
to regain control over shifting balance”. In paper II, the narrative synthesis revealed that 
a majority of the studies indicated that exercise can possibly induce positive 
neuroplastic changes in PwPD, but the evidence according to the GRADE analysis was 
very low. In paper III we found that a proposed design to explore associations between 
changes in behavioral outcomes and neuroplasticity after ten weeks of the HiBalance 
training was feasible and acceptable given a few modifications ahead of the RCT. Finally 
paper IV showed that people with mild to moderate PD exhibited impaired performance 
across most domains of gait when simultaneously having to concentrate on a cognitive 
task (dual tasking). Impaired cognitive function was associated with higher costs on 
gait, as well as a tendency to use a posture-second prioritization in which the cognitive 
task was prioritized over walking. 
Balance was perceived as both bodily equilibrium and a mind-body interplay. The 
meaning of balance was described through concepts of control and the ability to control 
one’s body in everyday life. Regarding exercise-induced neuroplasticity in PD, published 
studies showed promising results, but more high-quality RCTs, using scientifically 
sound methodology are needed in order to drive this research field forward. Our 
proposed RCT design to evaluate neuroplastic changes after the HiBalance training was 
feasible, but needed strengthening regarding blinding procedures, the MRI paradigm 
and the dual task gait assessment. Walking while simultaneously concentrating on a 
cognitive task impaired performance on both tasks, especially among those with 
cognitive impairment. These findings provide preliminary evidence to suggest that dual 
task training and assessment should be planned and instructed differently according to 




Det övergripande syftet med denna avhandling var att utforska uppfattningar och 
utförande av balans och gång hos personer med Parkinsons sjukdom (PmPS), samt att 
utvärdera både den tillgängliga evidensen för träningsinducerad neuroplasticitet, och 
genomförbarheten av att utvärdera träningsinducerade neuroplastiska förändringar hos 
PmPS. 
Denna avhandling inkluderar fyra studier av olika designer; en kvalitativ intervjustudie 
(studie I), en systematisk litteraturöversikt och meta-analys (studie II), en pilot RCT 
(studie III) och en tvärsnittsstudie (studie IV). Deltagarna i studie I, III & IV rekryterades 
via annonsering i tidningar samt via Parkinsonförbundet i Stockholm (n=18, n=13 och 
n=93 i respektive studie), medan studie II inkluderade studier via databassökningar 
(inkluderade studier n=13, totalt antal deltagare n=213) 
Den kvalitativa innehållsanalysen resulterade i fem huvudteman vilkas underliggande 
mönster bildade det övergripandet temat ”Fokus och beslutsamhet för att återvinna 
kontroll över en föränderlig balans”. I studie II visade den narrativa analysen att en 
majoritet av studierna pekade mot att en period av träning kunde inducera positiva 
neuroplastiska förändringar hos PmPS, men den sammanvägda evidensen enligt 
GRADE var väldigt låg. I studie III fann vi att den föreslagna RCT designen för att 
utvärdera associationer mellan förändringar i beteendemått och neuroplasticitet efter 
tio veckors högutmanande balansträning var genomförbar givet några modifikationer 
inför den större studien. Slutligen visade studie IV att personer med mild till måttlig PS 
försämrades i de flesta gångdomäner när de samtidigt fick koncentrera sig på en 
kognitiv uppgift. Kognitiv nedsättning var associerat med större grad av försämring vid 
gång, och personer med kognitiv nedsättning hade även en tendens till att prioritera 
utförande av den kognitiva uppgiften istället för gången. 
Balans uppfattades både som kroppens jämvikt och som ett samspel mellan kropp och 
sinne. Betydelsen av balans beskrevs i kontexten av kontroll och förmågan att 
kontrollera kroppen i dagliga livet. Gällande träningsinducerad neuroplasticitet vid PS 
så visade de publicerade studierna positiva resultat, men fler högkvalitativa RCT studier 
där man använt vetenskapligt sund metodologi behövs. Vår föreslagna RCT design för 
att utvärdera neuroplastiska förändringar efter HiBalance träningen var genomförbar, 
men behöver stärkas med avseende på blindning, upplägg av MRI undersökning samt 
gång-undersökning med samtidig kognitiv uppgift. Vid gång med samtidig kognitiv 
uppgift försämrades utförandet på båda uppgifterna, speciellt hos personer med 
kognitiv nedsättning. Dessa resultat påvisar preliminär evidens för att undersökning 
och träning av att gå och samtidigt utföra en kognitiv uppgift skall planeras och 
instrueras olika beroende på kognitiv förmåga.  
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DEFINITION OF CONCEPTS 
 
Dual tasking “The concurrent performance of two tasks that can be 
performed independently, measured separately and have 
distinct goals.”6 
Exercise “A physical activity that is planned, structured, repetitive, 
and purposive in the sense that improvement or 
maintenance of one or more components of physical 
fitness is an objective.”7 
Idiopathic PD Parkinson’s disease with an unknown cause. 
Neural Plasticity “Any change in neuron structure or function that is 
observed either directly from measures of individual 
neurons or inferred from measures taken across 
populations of neurons.”8 
Meta-analysis “The use of statistical techniques in a systematic review to 
integrate the results of included studies.”9 
Meta-synthesis “Qualitative approach for drawing inferences from similar 
or related studies, identifying key features and presenting 
findings representative of all data.”10 
Pilot study ”A study in which a future study or part of a future study, 
is conducted on a smaller scale to ask the question 
whether something can be done, should we proceed with 







Choosing a title that captured the essence of over four years of work was challenging. 
As some of the words in this title hold more than one interpretative possibility, this first 
section is devoted to introducing their meaning in the context of this work. 
Balance is a word that can have many meanings as well as synonyms. Throughout the 
greater part of this thesis I have chosen to use the word balance as opposed to postural 
control or balance control, mainly as a way to be consistent but also because this is a 
word that most people can relate to. There are however slight theoretical differences 
between these constructs. I have therefore used one of the other synonyms in some 
paragraphs, especially when I considered findings from other researchers to be more 
correctly interpreted when the original word was used.  
The concept of perception as used in this thesis relates to the naturalistic theory of 
perception, i.e. to the nature of perceiving.12 This is not to be confused with sense-
perception which merely concerns how we observe and recognize objects using our 
bodily organs. How we perceive things in the naturalistic sense varies from person to 
person and depends on for example, memories, expectations and emotions. Because we 
as humans perceive things differently, we also create different ways of knowing and 
understanding. 
This thesis is based on a foundation of pragmatism and the belief that both subjective 
and objective knowledge should be valued. It therefore utilizes methodological 
pluralism as a means of exploring balance and gait in PD from both these perspectives. 
Balance and gait impairments, as will be outlined in the following sections, with their 
basic yet complex manifestations affect the lives of people with Parkinson’s disease 
(PwPD) at several levels from the very onset of the disease. By focusing on both the 
perceptions and performance of balance and gait, we can not only develop a better 












2.1 PARKINSON’S DISEASE 
The first medical description of Parkinson’s disease (PD) dates back more than two 
centuries, to a case series in which James Parkinson described six people with 
“involuntary tremulous motion” and with a propensity to bend the trunk forward.13 
Since then, research efforts have elucidated a much fuller description of the 
symptomatology and anatomical origin of PD, as well as developed various treatment 
designs.14 There is still however much work to be done, and many questions to be 
answered. What we do know is that PD is a neurodegenerative disease, the 
pathophysiology of which involves the loss of dopaminergic neurons in the basal 
ganglia-related nuclei substantia nigra pars compacta (SNpc). The basal ganglia and 
related nuclei can be categorized into input, output and intrinsic nuclei. The input 
nuclei, which consists of the putamen, caudate nucleus and accumbens nucleus, are 
those structures that receive information from other parts of the brain. The output 
nuclei – globus pallidus and substantia nigra pars reticulata, are instead responsible for 
communicating basal ganglia information to the thalamus. Finally, placed between the 
input and output nuclei are the intrinsic nuclei SNpc, the external segment of the globus 
pallidus and the subthalamic nucleus. The intrinsic nuclei relay information between 
the input and the output structures. For the basal ganglia system to function properly, 
it requires dopamine to be released to the input nuclei.15 Through complex 
communication with the cerebral cortex and the cerebellum, the basal ganglia is a main 
regulator of not only planning movements, but also of the cognitive processes involved 
in movement strategies and emotions and motivation that help drive movement 
behavior.16 The alterations in the basal ganglia-cortical-cerebellar pathways caused by 
dopamine depletion in PD result in both motor and non-motor symptoms, as will be 
described in later paragraphs. A pathological hallmark of PD is the presence of protein 
aggregates called Lewy bodies. Based on the spreading of Lewy bodies, Braak and 
colleagues suggests that PD progresses in six stages, starting in the dorsal motor nucleus 
of the vagus nerve and moving in an upward course through the brain, finally extending 
to the cerebral cortex.17 Although corresponding to disease initiation and progression 
in a majority of PD cases, the Braak staging system does not seem to be valid for all PD 
subgroups and therefore needs further elucidation.18  
2.1.1 Diagnosing a person with PD 
Diagnosing an individual with PD is commonly done using the UK Parkinson´s Disease 
Society Brain Bank clinical diagnostic criteria, a three-step diagnostic tool. In the first 
step a diagnosis of Parkinsonian syndrome is made if an individual present with 
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bradykinesia and at least one of the following: rigidity, rest tremor or postural 
instability. In step two, a number of exclusion criteria are controlled for, and in step 
three a number of supportive criteria are controlled for. At least three supportive 
criteria, for example unilateral onset or progressive disorder, are required for a diagnosis 
of PD.19 In 2015, the Movement Disorder Society (MDS) proposed revised criteria for PD 
diagnosis, intended to be used both in research and as a clinical guide.20 Unlike the UK 
Brain Bank Criteria, the MDS version does not include postural instability in the first 
step when diagnosing parkinsonism. A diagnosis of PD is then established if there is 1) 
absence of absolute exclusion criteria, 2) at least two supportive criteria, and 3) no red 
flags (for example early bulbar dysfunction or inspiratory respiratory dysfunction). The 
reason, stated by the MDS,  for removing postural instability as a criterion for 
parkinsonism caused by PD is that early presence of impaired balance may suggest an 
alternative diagnosis.20 
2.1.2 Epidemiology and etiology 
Over 6.1 million people worldwide live with PD,21  and of these approximately 22 000 
reside in Sweden.22 Parkinson’s disease is now the fastest growing neurological 
disorder.23 The prevalence differs in relation to sex, age and geographic location among 
other factors. There is a male preponderance in all age groups, 24 and it has been 
suggested that estrogens may have a protective effect in women, but also that men 
might be at higher risk of PD because of recessive susceptibility genes on the X 
chromosome and a higher frequency of occupational toxin exposure as well as minor 
head trauma.25 Prevalence rises with age, from 41 per 100 000 in individuals 40 to 49 
years, to 1903 per 100 000 in individuals over the age of 80.24 A majority of included 
participants in this thesis were  ≥60 years of age as this was an inclusion criteria for 
papers III and IV. This is also representative of the distribution of PwPD in Sweden as 
over 90% are ≥60 years (45.6% women).22 
2.1.3 Pharmacological and surgical treatment 
As of today, all available therapy options are symptomatic, meaning that they are not 
curative, neuroprotective or disease-modifying in nature. Pharmacological treatment 
differs depending on the target symptom. Medication for the relief of motor symptoms 
are primarily based on dopamine, whereas drugs targeting non-motor symptoms are 
mostly based on other neurotransmitters such as serotonin, acetylcholine and 
norepinephrine.26 Dopaminergic therapies are drugs that either stimulate dopamine 
receptors or enhances intracerebral dopamine concentrations, and include for example 
levodopa, dopamine agonists and monoamine oxidase type B inhibitors.27 
Unfortunately, long term dopaminergic therapies may come with side effects. These 
include dyskinesias (involuntary dystonic or choreiform movement), and motor and 
non-motor fluctuations.26 Fluctuations are alterations between periods of good 
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symptom control (referred to as ON) and periods of reduced symptom control (referred 
to as OFF).27 
Both dopaminergic and cholinergic systems are implicated in cognitive impairment in 
PD, and pharmacological treatment results are variable. Dopaminergic treatment 
effects on cognition vary with task demand, whether the person has cognitive 
impairment, genetic factors and other aspects. Cholinesterase inhibitors have a 
documented positive effect on cognition and behavior in PD dementia (PDD), but 
evidence is less documented in PD mild cognitive impairment (PD MCI).28 
Surgical treatment for motor symptoms can be considered in moderate to severe PD 
and usually entail deep brain stimulation of globus pallidus interna or the subthalamic 
nucleus.27 People  who have undergone  deep brain stimulation are under-represented 
in this thesis as this surgical treatment was an exclusion criteria for papers III-IV, and 
for several of the included studies in paper II. 
2.1.4 Motor symptoms 
The cardinal motor symptoms of PD include bradykinesia, muscular rigidity, rest 
tremor and postural instability.27 The focus of this thesis will be on postural instability, 
here referred to as balance impairments, but the first three motor symptoms will be 
briefly outlined as they will be evaluated and/or discussed throughout all included 
papers. Bradykinesia entails a slowness when initiating movements, and a reduction in 
speed and amplitude when performing repetitive actions. Hypomimia, the loss of facial 
expressions, is one example of bradykinesia. Rest tremor usually presents in the upper 
extremities, but with disease progression may also occur in the lower extremities, face 
and neck. Rigidity is an increased muscle tone causing stiffness of both the limbs and 
trunk.29 The most commonly used scale to assess disease severity, the Hoehn and Yahr 
scale (H&Y scale), is based on clinical motor symptoms and functional disability. In its 
original version, the scale is from 1-5, with 1 meaning  “unilateral involvement only 
usually with minimal or no functional disability” and 5 meaning “confinement to bed or 
wheelchair unless aided”.1 Scoring on the H&Y scale is usually preceded by an 
examination of motor function according to the MDS Unified Parkinson’s Disease 
Rating Scale (MDS-UPDRS) part III.3 The MDS-UDPRS scale, which in its entirety 
consists of four parts is a more comprehensive measure of disease severity. Throughout 
this thesis the H&Y scale and the MDS-UPDRS has been used to describe disease 




2.1.5 Non-motor symptoms 
Non-motor features of PD are under-recognized and under-treated even though they 
are common and often precede motor symptoms.27  Non-motor symptoms include 
neuropsychiatric symptoms such as depression, anxiety, apathy and cognitive 
impairments, but also sleep impairments, autonomic symptoms, gastrointestinal 
symptoms and sensory symptoms.27 Impaired ability to communicate is another set of 
non-motor symptoms prevalent even in the earlier stages of PD. A survey study in 
Sweden revealed that within the first five years of PD diagnosis, 44% experienced 
worsening of speech.30 The three most frequently reported symptoms related to speech 
and communication were weak voice, problems with word-finding and imprecise 
articulation.30 In paper III, the control group intervention (HiCommunication) 
specifically targets speech and communication impairments.  
2.1.5.1 Cognitive impairment 
Impaired cognitive function in PwPD ranges on a spectrum from subjective symptoms 
(with unimpaired performance on cognitive tests), to PD MCI; a transitional zone in 
which cognitive impairment is present, but where functional activities of daily living are 
mainly preserved, and PD dementia (PDD).31 It has been noted that even at time of 
diagnosis, approximately 15-20% have developed PD MCI.32 Longitudinal studies of 
incident cohorts have shown that two-thirds of PwPD in the early stages will develop 
cognitive impairments within 3.5 years from disease onset.33, 34 Approximately 50% of 
PwPD will develop dementia within 10 years, and 80% within 20 years of diagnosis.35  
It is well established that executive function is especially affected among  PwPD 
compared to healthy controls.36, 37 Executive function is an umbrella term for several 
different actions primarily executed from the prefrontal cortex (PFC) in relation to goal 
directed behavior. Miyake et al advocates that executive function incorporates 
inhibition, working memory-updating, and cognitive flexibility, and concludes that 
these  functions contribute differentially to complex executive function tasks.38 
Executive function is what we rely on in moments when we need to concentrate and 
pay attention and involves the mental processes we use in moments when we cannot or 
should not rely on automatic or instinctual behavior.39 In PwPD, impaired executive 
function results in various problems with, for example, set shifting, planning, inhibition, 
decision making and dual-task performance.36 Moreover, impaired executive function 
may be related to other non-motor symptoms such as depression and apathy, but also 
to motor symptoms such as balance and gait impairments.36   
2.2 A FOCUS ON BALANCE AND GAIT 
Balance and gait impairments are independent measures of mobility and are often 
evaluated separately, but due to their overlapping nature they will be discussed here in 
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tandem. Deterioration of balance and gait ability occurs in line with PD progression, 
but may be present at all stages of the disease, even at time of diagnosis.40   
2.2.1 Neurophysiology 
Balance and gait are controlled through voluntary movements and automatic processes. 
Our goal-directed movements start by a command from the cerebral cortex which is 
then transferred to the brainstem and the spinal cord. The automatic processes include 
regulation of muscle tone and balance adjustment. The cerebellum acts as a regulator 
between volition/cognition and automatic processes, whereas the basal ganglia has 
been suggested to modulate each process through its projection of gamma-
aminobutyric acid (GABA) to the cerebral cortex and the brainstem.41 
Although PD is primarily associated with impaired basal ganglia function, one cannot 
overlook the impact that alterations to other brain structures and functions has on 
balance and gait.42 According to a framework of supraspinal locomotor control in PD, 
slowness of gait is related to an altered basal-thalamo-cortical loop and an impaired 
function of the cholinergic system. Gait variability and asymmetry increase as the 
volitional control of gait increases as a response to decreased automatic control. Lastly, 
balance impairments are related to impaired function in brainstem activity.42   
2.2.2 Constructs of balance and gait 
Horak and colleagues have previously suggested a framework for understanding the 
complex nature of balance. They defined six domains that affects balance: 
biomechanical constraints, stability limits, anticipatory postural adjustments, postural 
responses, sensory orientation, and stability in gait. According to this model, weakness 
of ankles or hips, as well as stooped/flexed posture (i.e. constraints to the biomechanical 
system) can lead to compensatory steps or the use of ankle strategy when recovering 
balance. Stability limits refers to how far we can move our center of mass over our base 
of support and constraints to these limits may lead to body tilt or inflexible postural 
alignment. Anticipatory postural adjustments (APAs) are as the term implies the small 
adjustments, we make to stabilize ourselves before initiating movements. Constraints 
in APAs lead to increased instability in for example gait initiation or when rising from a 
chair. Our postural responses concern the speed, amplitude and strength with which 
we respond to slips, trips and pushes. Sensory orientation relies on our vestibular system 
and the capacity to integrate sensory information, and constraints in this domain may 
lead to disorientation and instability. Finally, stability in gait concerns both the dynamic 
coordination between the spinal cord and the brain stem, as well as executive and 
attentional control.43  See Fig 1 for an overview of the main concepts of the described 
model. This framework forms the basis of a main outcome measure in this thesis – the 
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Mini Balance Evaluation Systems Test (the Mini-BESTest), 4 as well as the intervention 
in paper III.44 
 
Figure 1. Model of systems underlying postural control. Modified from Horak et al, 43 
with print permission from Oxford University Press. 
Gait disturbances in PD are either continuous or episodic,45 and various techniques such 
as electronic walkways and body-worn sensors can be used to quantitatively capture 
these outcomes throughout the gait cycle. Examples of episodic disturbances of gait are 
festination, which involve rapid and small steps in combination with an involuntary 
forward leaning of the trunk and freezing of gait where the person temporarily 
experiences an inability to move the feet forward. Even though episodic disturbances of 
gait are very debilitating, this thesis is mainly concerned with continuous gait. Lord et 
al used principal component analysis on 16 gait parameters in order to build a model for 
understanding continuous gait in PwPD. Five independent domains of gait were 
identified: pace, rhythm, variability, asymmetry and postural control,46, 47 see Figure 2 
for an overview of this model. Within these domains are gait parameters that are either 
spatiotemporal characteristics of gait, expressed as means over several steps, or dynamic 
features which are measures of variability in the spatiotemporal characteristics. As seen 
in Figure 2, some domains contain measures of both spatiotemporal and dynamic 
characteristics, whereas the variability domain solely contains dynamic measures.  














Figure 2.  Model of continuous gait domains. Modified from Lord et al, 47 with print 
permission from John Wiley and Sons. 
2.2.3 Gait characteristics in PD 
Even in the early stages of PD subtle alterations of gait are noticeable - gait speed slows 
down, step length shortens and arm swing amplitude decreases. Later, in the mild to 
moderate stages these changes progress, and usually also manifest bilaterally. This is 
the stage where the typical parkinsonian gait emerges, with shuffling steps and stooped 
posture. Problems with turning and gait initiation might appear now, as well as 
festination and freezing of gait. In the advanced stages of the disease, gait changes are 
more severe, and further complicated by motor fluctuations and dyskinesia.48 
Compared to healthy controls, PwPD present with alterations in all gait domains, but 
typically most pronounced in the pace, variability and asymmetry domains.49 The 
combination of reduced gait speed and increased variability is considered to especially 
predispose to an increased risk of negative outcomes, such as falls.42  A longitudinal 
study, following PwPD from diagnosis, revealed that at the last follow-up (54 months 
following diagnosis), 79.7% had fallen. Of these, 10.7% had fallen once, whereas as 89.3% 
were recurrent fallers.50 
2.2.4 Dual task and related terminology defined 
Dual tasking has been defined as “the concurrent performance of two tasks that can be 
performed independently, measured separately and have distinct goals”.6 By this 

























the combination of one motor task and one cognitive task. In this thesis, I will primarily 
focus on the latter. The term interference is commonly used to describe that 
performance of a certain task is interrupted by a second task which is performed 
simultaneously. In this thesis, I use the terms DT effect to describe the overall effect, 
DT cost to indicate a decline in performance and DT benefit to indicate improvement 
in performance.  
Different possible scenarios for how performance during motor-cognitive DT compares 
to single task execution have been described by Plummer et al.51 They have further 
illustrated this pattern of motor-cognitive interference in a conceptual model,52 see 
Figure 3 for a modified version. In this model, the DT effect as expressed in percent (%) 
for each of the tasks (i.e. the ratio from single to DT performance) are plotted. 
Depending on where in the graph the dot is located, one can interpret whether it was a 
DT cost or DT benefit on respective task, and also to what extent one task may have 
been prioritized over the other. With this in mind, it is important that we evaluate the 
DT effect on both tasks, and not focus on gait alone. Prioritization may have important 
clinical implications as it has previously been suggested that PwPD use a hazardous 
posture-second strategy.53 In Figure 3, a dot in the upper left quadrant implies a posture-
first strategy, and a dot in the lower right quadrant a posture-second strategy. 
 
Figure 3. Potential patterns of interference or facilitation when performing a motor-
cognitive dual task, modified from Plummer et al.52 
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2.2.5 Possible theories on the dual task paradigm 
A key feature of PD is the gradual loss of automaticity. Automaticity in this context 
relates to the performance of movements without having to direct attention towards 
the details of those movements.54 Imaging studies have revealed that in the healthy 
brain, as a movement becomes automatic, brain activity decreases in several areas (for 
example in the dorsolateral PFC and the anterior cingulate cortex which are both 
important for attention), but the connectivity between different motor areas and the 
putamen instead increases.55 In PD, due to  dopamine depletion in the putamen, no 
such increase in connectivity strength to motor areas takes place, which leads to 
difficulties in acquiring automaticity.55  
What this loss of automaticity leads to in terms of balance and gait is that PwPD shift 
from an automatic processing to an executive control strategy during movement. Using 
this compensatory strategy for ambulation is concerning for multiple reasons. One 
disadvantage is that compared to automatic processing, it takes a longer time for the 
cerebrum to process peripheral inputs. It is also possible that using executive control 
for ambulation may tax the available executive resources. Lastly, an executive control 
strategy is more susceptible and sensitive to stressors in the environment, for example 
a busy street-crossing, which can potentially lead to a deterioration in locomotor 
control.56 
Compared to healthy controls, people with neurological disease typically experience 
more difficulties when performing two or more tasks simultaneously.57, 58 Although not 
yet fully understood, it is believed that the loss of automaticity, together with impaired 
executive function and decreased attentional resources may partly explain the impaired 
ability to DT .55 Two of the most widely accepted theories of DTs and how they affect 
performance are the capacity-sharing theory and the bottleneck theory. Whereas the first 
relates to how DT effects are caused by a limited amount of processing capacity, the 
latter postulates that interference occurs when two tasks use the same neural processor 
leading to a serial processing and a delay and/or impairment in performance. Both 
theories, however, are also described as potentially, yet partially, voluntary, meaning 
that individuals to some extent can choose which task to prioritize.59 
2.2.6 Dual tasking in PD 
Gait impairments during DT walking are well documented in PwPD. Most reported are 
DT costs within the pace domains, with decreased gait speed, 60-69  step length, 60, 64, 65, 
68, 69 and increased swing time variability 60, 65, 69. It is perhaps not surprising that most 
DT costs are reported from the pace domain, as most studies reporting on gait tend to 
use speed as the priority outcome. There are however reports on DT costs also within 
the rhythm domain, 64, 65, 67-69 and variability domain 61, 65, 66, 69. Given the heterogeneity 
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in type of DT used and gait parameters reported, combining data from studies is 
problematic. To date, only one meta-analysis exists where data from existing literature 
on DT costs on gait speed have been aggregated.70 Using a random effects model, data 
on  single and DT gait speed from 28 studies were meta-analyzed. Results showed a 
medium to large effect size for reduced gait speed when adding a DT.  
2.2.7 Perceptions of balance and gait in PD 
For all we currently know about the quantitative measures and manifestations of 
balance and gait in PD, far less is known about the experience of these impairments. 
We cannot measure the depth of human experience in numbers. Rating an emotion or 
ranking a situation is far from understanding the extent of a personal experience. In 
interviews, PwPD have described how progressively impaired balance lead to emotional 
distress.71 It may manifest in a fear of falling which creates a sense of insecurity in 
everyday life situations and may lead to activity avoidance.72 There is a large divergence 
in how different individuals with PD perceive balance and falls, with some describing 
falls as unavoidable and non-dramatic, while others catastrophize falling.71 Walking has 
been described as attention-demanding, especially in narrow spaces or when 
negotiating obstacles. Narrow spaces can induce feelings of discomfort, of being 
constrained or even suffocated.73 Concentrating on walking is required even at an early 
stage of the disease in order to maintain basic rhythm and cope with distractions, 
something that is experienced as both tiring and frightening at times.74 
2.2.8 Exercise and training interventions for balance and gait 
Compared to other PD motor symptoms, balance and gait impairments are less 
responsive to levodopa treatment.75 Gait speed and step length, both variables within 
the pace domain, do improve to some extent with levodopa, while other gait parameters 
and balance are unaffected or even worsened.76 This unresponsiveness may be 
explained by gait and balance being more influenced by an impaired function of the 
cholinergic system, as opposed to the dopaminergic system.49, 77 Although levodopa 
medication does not successfully improve or manage these symptoms, balance and gait 
seem to respond well to other management options such as physical therapy and 
exercise, therapies which are therefore recommended as an adjunct to levodopa by the 
Movement Disorder Society.78 
Although exercise is widely accepted as a non-pharmacological treatment, there is still 
a paucity in the synthesized evidence of its effect in PD. This is not due to a lack of 
published articles on the topic, but rather due to the problematic issue of aggregating 
data with heterogenous interventions and heterogenous outcomes. One of the most 
frequently cited Cochrane review on this topic, found evidence for the benefits of 
physical therapy in the short term (less than three months) for outcomes concerning 
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balance and gait speed and functional mobility. The meta-analyses are however based 
on few studies and should be interpreted with caution.79 An update review by the same 
group  also concludes that there is not enough evidence to favor one physical therapy 
intervention over another, in the short term.80 It  seems however, that when comparing 
the long term effects of training, that balance training followed by gait training are the 
modalities with the longest carry-over effects, with results maintained for 6-12 months.81  
2.2.9 HiBalance 
As part of the project Balance Elderly Training and Activity in Parkinson’s Disease 
(BETA-PD) our research group has developed the HiBalance program.44 This is an 
intervention consisting of highly challenging balance exercises that target four areas of 
balance commonly impaired in PD (sensory orientation, APAs, stability in gait and 
stability limits).44, 82 The ten-week, supervised, group-training is founded on basic 
training principles such as specificity, progressive overload and variability.83, 84 As part 
of the progression, both cognitive and motor DTs are incorporated with the balance 
exercises. The HiBalance program has been evaluated both in a controlled research 
environment,82 and as implemented in clinical practice.85 To what extent the 
improvements shown on balance and gait function after the HiBalance training 
correlates with changes in the brain has however not yet been determined. 
2.3 NEUROPLASTICITY AND EFFECTS OF EXERCISE 
2.3.1 Defining and investigating neuroplasticity 
Neuroplasticity relates to the potential of the central nervous system to modify itself in 
response to internal and external pressures. In short, it is the way in which neurons alter 
their structure and function.86 Although most often discussed as something positive, 
abnormalities in behavioral and neural signals can also give rise to maladaptive 
plasticity such as epilepsy, neuropathic pain, tinnitus and dystonia.8 Neuroplastic 
changes can be measured at several levels; molecular, cellular, structural, functional and 
behavioral.87 Behavior in this respect relates to for example motor, cognitive or sensory 
changes, and these are indirect measures of neuroplasticity.8  There are several different 
techniques for  evaluating neuroplasticity at these various levels, and the choice of 
methodology needs to be determined by the research question. As part of this thesis I 
have explored feasibility aspects of investigating neuroplastic changes at the molecular, 
structural, functional and behavioral levels. There are many different techniques 
available, but in this background, I will only introduce the methods used in paper III. 
On a molecular level Brain-Derived Neurotrophic Factor (BDNF), a nerve growth factor 
that promotes synaptic plasticity as well as neuronal survival and regeneration, can be 
detected in blood or cerebrospinal fluid. Levels of BDNF are reduced in PD compared 
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to healthy controls88 , and it appears that the reduction is more intense in the early 
stages of the disease.89 At the structural and functional levels, different brain imaging 
techniques can help researchers understand the complex networks of interconnected 
neurons of the human brain. Techniques based on magnetic resonance imaging (MRI) 
allows researchers to investigate cortical thickness, regional cerebral blood-flow, task-
evoked brain responses and functional connectivity among other factors.90 The 
exploration of brain structural and functional changes and how they relate to behavioral 
changes after an intervention is becoming an increasingly popular way of evaluating the 
potential effect an intervention has on neuroplasticity.91 
2.3.2 Exercise-induced neuroplasticity in PD 
Over the last decades there has been an increasing interest in whether physical exercise 
has neuroprotective mechanisms in PD.92, 93 Animal studies indicate that physical 
exercise may have the ability to induce neuroplasticity in PD, 94-97 but few studies have 
thus far been conducted on humans. Human clinical studies are not only scarce, but 
unfortunately also difficult to draw conclusions from, or to compare due to several 
reasons.  The handful of reviews which have set out to compile the evidence do however 
point in a positive direction, towards exercise having a possible neuroprotective effect in 
PD.92, 93, 98-100 Small sample sizes, heterogeneous interventions, heterogeneous 
evaluative methods of neuroplasticity, as well as underreporting or missing information 
on correlations between behavioral improvement and changes in neuroplastic 
outcomes, to name a few examples of the challenges faced when attempting to 
synthesize the current evidence.   
2.4 THEORETICAL CONSIDERATIONS 
This thesis intended to use a holistic approach to research, in which an individual is 
seen as a whole and not only as a sum of its parts. The International Classification of 
Functioning, Disability and Health (ICF), endorsed by the World Health Organization 
in 2001, is a holistic framework where one looks at disability not merely through the 
lens of medicine or biology, but also at the impact that it has on a person’s functioning 
and life experience.2 Within the ICF framework the health condition is classified 
according to Body Structure and Function (physiology and anatomy), Activity (how a 
task or an action is executed) and Participation (involvement in life situations) while 
also considering Contextual factors (environmental and personal).2 This thesis uses the 
ICF to classify and map out the multitude of outcome measures, while also 
complementing with other theories and conceptual models for interpretation of 




Exercise and physical therapy can improve balance and gait function in PwPD,79, 81 yet 
the majority of this population does not uphold optimal levels of physical activity.101-103 
Sustained engagement in exercise is important as it is perceived by PwPD to improve 
both physical and psychological symptoms, and thereby enhances the overall sense of 
well-being and quality of life.104 Barriers to exercise are spread throughout the ICF 
domains,105, 106 and as therapists we need to understand how we can help our clients 
overcome them. However, in order to better interpret the barriers, we need to gain an 
understanding of how PwPD perceive their symptoms and how they make sense of 
them.  
Over the last decades the increased interest in exercise-induced neuroplasticity has 
resulted in a number of experimental studies in both animals and humans with PD. 
Synthetizing findings and establishing current evidence within this field of research 
may help develop a neurorehabilitation which focuses on therapies that maximizes 
neuroplasticity. To date however, only one review published on this topic has been 
conducted in a systematic manner, but this focused on one neuroplastic outcome only.93 
There is a need to do an updated systematic review of the field in order to synthesize 
current evidence across all possible outcomes of neuroplastic changes induced by a 
period of exercise. In order to move this body of research forward we also need to 
establish what components of our evaluative methods and our interventions that are 
feasible to perform and acceptable to the people we serve. In line with this, we now also 
seek to explore the feasibility of evaluating any associations between behavioral 
improvements after the HiBalance training with neuroplastic changes.   
Impaired DT abilities are well-recognized in PwPD, and much research has been done 
to explore how gait is affected and to what extent tasks are prioritized differently 
compared to healthy controls.70, 107 Few studies have however explored DT impairments 
across all domains of gait, and perhaps even less reported is the cost on the secondary 
task. Without a complete description of all gait parameters and on the secondary task, 
we cannot fully understand the extent of the DT impairment or of the strategy used. It 
has been suggested that PwPD use a posture-second strategy whereby they prioritize 
the cognitive task at the expense of safe walking,53 but to what extent this is equally true 
in individuals with and without PD MCI has been questioned.108  Given the 
heterogeneity in cognitive profiles among PwPD, it is of further interest to explore to 







The overall aim of this thesis was to explore perceptions and performance of balance 
and gait in PwPD, and to evaluate both the current evidence for exercise-induced 
neuroplasticity and the feasibility of investigating exercise-induced neuroplastic 
changes among PwPD. 
 
3.1 SPECIFIC AIMS 
 
Paper I 
To explore the meaning of balance for PwPD and the beliefs they hold regarding their 
ability to influence their balance in everyday life. 
 
Paper II 
To establish the current evidence on postintervention effects of a period of physical 
exercise on neuroplasticity in PwPD.  
 
Paper III 
To systematically evaluate the process and scientific feasibility of a trial design to 
investigate exercise-induced neuroplasticity of the HiBalance program in people with 
mild to moderate PD.  
 
Paper IV 
To explore DT effects during simultaneous performance of a motor task (gait) and a 








Paper I used a qualitative design. Paper II was a systematic review and meta-
analysis. Paper III was a pilot randomized controlled trial. Paper IV used a cross-
sectional design. For the purpose of increasing reading comprehension, the studies 
will be explained separately or combined, as appropriate, in the methods section. The 
following paragraphs outline details of the different methods used in the papers, and an 
overview can also be found in Table 1. 
4.2 PARTICIPANT AND STUDY SELECTION 
4.2.1 Recruitment and eligibility criteria 
Papers I, III-IV 
Participants were recruited through advertisements at the Swedish Parkinson 
Association and in local newspapers. Sampling methods differed between paper I and 
studies III-IV, which naturally led to eligibility criteria differing somewhat. Two overall 
criteria for inclusion in papers I and III-IV were that participants I) had a diagnosis of 
idiopathic PD, and II) scored ³21 on the Montreal Cognitive Assessment (MoCA).5 This 
test of global cognitive abilities is brief and has a maximum score of 30, and is widely 
used as a screening tool for possible cognitive impairment in PD.109 Participants were 
excluded if they scored <21 as this is the recommended cutoff for possible dementia. In 
paper I, people of all ages, and in Hoehn and Yahr stages I-V, were considered for 
inclusion, whereas in paper III and IV, participants had to be ³60 years of age and in 
Hoehn and Yahr stages II-III. In paper I, recruitment was based on a maximum variation 
sampling, as our intention was to include participants with different experiences of 
balance.110 We therefore strived to include participants who differed with regard to time 
since diagnosis, age, sex, physical activity level, and self-perceived balance, etc. In 
studies III and IV, on the other hand, a purposive sampling method with narrower 
inclusion and exclusion criteria was used. The reasons for this were multifold, but the 
primary one was that these studies build and extend on previous explorations of the 
HiBalance program with similar eligibility criteria.82 We also had to add exclusion 
criteria for safety reasons in the MRI environment. Due to this environment, some 
specific exclusion criteria were added for paper III, and by extension also for paper IV, 
as this was based on baseline data for a larger RCT, where MRIs are performed. 




Table 1. Overview of design and methods for papers I-IV. 
 Paper I 
(n=18) 
Paper II 
















searches in: Medline, 







Setting Participants’ home 
University 













Descriptive statistics Descriptive statistics 
Linear regression 
Study population     
  Age, mean (SD) 69.8 (8.6) 64.6 (7.6)a 69.2 (5.1) 71.0 (6.1) 
  Sex, women n (%) 9 (50.0) 75 (38.1)a 4 (30.8) 34 (36.6) 
  Hoehn & Yahr, range 1-4 1-3a 2-3 2-3 
  MoCA, mean (SD) 25.4 (2.9) NA 26.5 (2.1) 25.8 (2.4) 
  Years with PD, mean (SD) 8.8 (5.7) NA 8.0 (3.2) 5.2 (4.5) 
*See Table 3 for detailed information on descriptive and inferential statistics used in the thesis. 




In order for studies to be eligible for inclusion in the systematic review, they were to be 
intervention studies conducted on humans with idiopathic PD. The intervention of 
interest for our aim included any type of physical exercise performed repeatedly (i.e., 
performed on more than one occasion). We also included studies where the 
intervention was a combination of physical and mental training, as long as the majority 
of the intervention was the physical exercise part. Studies were not excluded based on 
any of the following criteria: disease stage, age, sex, medication, publication date or 
language. Studies were, however, excluded if they only examined acute effects (<24 
hours) of exercise, or if in a combined intervention the mental training made up the 
majority of the intervention. 
4.3 ETHICS 
All studies within the thesis were conducted according to the ethical principles of the 
Declaration of Helsinki. 112 Papers I, III and IV were approved by the regional ethical 
board in Stockholm County with the following registration numbers: 
Paper I: 2016/201-31/2 with amendment 2016/1973-32 
Papers III and IV: 2016/1264-31/4 with amendments 2017/1258-32 and 2017/2445-32 
4.4 DATA COLLECTION 
Data collection for this thesis commenced in November 2016 and concluded in 
September 2019. The setting depended on where data was collected or intervention was 
performed, and varied among participants’ homes (paper I), university settings and/or 
clinical settings (papers II-IV). For clinical testing of balance, gait and motor function 
in papers I and III-IV, participants were assessed in their ON stage of levodopa 
medication. See Table 2 for the full list of self-rated as well as clinically assessed 










Table 2. Overview of self-rated and clinically assessed outcomes reported in papers I, III and IV 
Outcome Instrument Paper 
I III IV 
Contextual factors     
Age Interview • • • 
Sex Interview • • • 
Education Interview   • 
Years since diagnosis Interview • • • 
Disease severity Hoehn & Yahr scale • • • 
Medication Levodopa Daily Equivalent Dose  • • 
History of falls Interview • • • 
Walking aids Interview •   
Body function & structure    
Body mass Body Mass Index  • • 
Brain structure Magnetic Resonance Imaging (MRI)  •  
Brain function Resting state functional MRI (fMRI)  •  
 Task evoked fMRI  •  
Nerve growth factor Brain-Derived Neutrophic Factor in blood plasma  •  
Motor function  MDS-UPDRS III • • • 
 MDS-UPDRS IV   • 
Speech Voice intensity  •  
 Dysarthria  •  
 Word intelligibility  •  
 Sentence intelligibility  •  
Global cognition Montreal Cognitive Assessment • • • 
Executive function Trail Making Test, trial IV  • • 
 Color Word Interference Test  • • 
 Verbal fluency  • • 
Attention/working memory Trail Making Test, trials I-III  • • 
 Digit span  • • 
Episodic memory Brief Visuospatial Memory Test – Revised (BVMT-R)  • • 
 Rey Auditory Verbal Learning Test (RAVLT)    
Visuospatial functions Copy condition from BVMT-R  • • 
Depression and anxiety Hospital Anxiety and Depression Scale  • • 
Experiences of daily living MDS-UPDRS I  • • 
 MDS-UPDRS II  • • 
Activity & participation 
Balance Mini Balance Evaluation Systems test • • • 
 Activities-specific Balance Confidence Scale • • • 
Gait/walking Electronic walkway*  • • 
 Walk 12 • • • 
Mobility Timed Up and Go • • • 
Physical activity Physical Activity Scale for the Elderly •   
 Frändin & Grimby  •  
 Accelerometer Actigraph  •  
Well-being 
 EuroQol 5 Dimensions, Index  •  
 EuroQol 5 Dimensions Visual Analogue Scale  • • 
 Parkinson’s disease Questionnaire -39  • • 
 
4.4.1 Paper I 
For paper I, semi-structured, in-depth interviews were performed by the author of this 
thesis. An interview guide with predefined themes and open-ended questions were 
developed and used. The interviews had an average length of 51 minutes (range 22-75 
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minutes) and were recorded using a digital Dictaphone (Olympus VN-741PC). All 
interviews were transcribed verbatim. For descriptive purposes, a second visit with the 
participants was conducted in order to perform clinical testing and to collect self-
reported questionnaires. The clinical testing was purposefully always scheduled after 
the interviews as we did not want the participants’ thoughts or views to be influenced 
by how they had performed on balance tests, or by the type of questions posed in the 
questionnaires.  
4.4.2 Paper II 
A study protocol was established and registered in Prospero (ID CRD42017057834). 
After agreeing on a suitable search strategy among the authors, librarians assisted with 
performing exhaustive searches in February 2017 in the following databases: Medline 
(Ovid), Embase, Cinahl (EbscoHost) and PEDro. An update search was performed in 
November 2017. During the study selection phase, all studies identified through 
database searches were screened for eligibility by two review authors blinded to each 
other´s decisions using the web-based tool Rayyan. 113 Any disagreements after the 
initial screening were resolved through a third review author. The two initial reviewers 
then screened the potential articles in full text, once again blinded to each other’s 
decisions. After this screening process, a final decision was then taken as to which 
studies to include. (See paper II, Figure 1, for a PRISMA flow diagram of the screening 
process.) Data was then extracted based on predefined outcomes. Of special relevance 
was information on the neuroplastic outcome, but we also retrieved data pertaining to 
sociodemographic information, disease severity, eligibility criteria, setting and 
intervention (type, intensity, frequency and length), etc.  
4.4.3 Paper III 
Feasibility studies commenced before a future RCT are designed to evaluate whether or 
not the planned RCT can be done, and if so how. A pilot trial falls under the umbrella 
term of feasibility studies and is usually a smaller-scaled version of the future RCT.114 In 
conducting a pilot trial ahead of the future RCT, researchers are given the opportunity 
to evaluate various features of the design and an opportunity to make changes when 
needed. In pilot studies, the aspects of feasibility monitored can be grouped into 
process, resources, management and scientific.115 
In paper III, the main focus was on evaluating feasibility aspects of the trial design in 
order to support the development of a future, appropriately powered RCT. We primarily 
evaluated and reported process feasibility, such as recruitment rates and retention rates, 
and scientific feasibility, such as safety of interventions and trends in treatment 
response.115 The trial design was monitored from the study launch, i.e. from 
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advertisement and initial telephone screening, to study completion, i.e. until last post 
assessments (see Figure 4 for details). 
 
Figure 4. Timeline of the pilot trial, paper III, from study launch to study completion 
with overview of process and scientific feasibility outcomes 
Pre- and post-assessment sessions consisted of three sessions each. The first pre-
assessment session was done in order to confirm eligibility, and to evaluate physical 
function (balance, gait, motor function, etc.). The following two sessions consisted of I) 
structural and functional brain imaging, and II) evaluation of cognitive function as well 
as voice intensity and speech intelligibility. All three sessions lasted 90-120 minutes 
each. 
4.4.4 Paper IV 
Paper IV is based on baseline data from the EXPANd trial (see Franzén et al. for study 
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avoid fatigue. During the first session, eligibility was confirmed, and demographic 
information collected. Participants were then assessed based on balance and DT gait 
performance, as well as motor function. During the second session, participants were 
assessed with a neuropsychological test battery. Both sessions lasted 90-120 minutes 
each. 
4.4.5 Self-reported and clinically assessed outcomes 
In all studies, socio-demographic information was collected (papers I, III and IV) or 
extracted (paper II). The diagnosis of idiopathic PD was handled differently in the 
different studies. In paper I, a pragmatic approach was chosen in which information 
regarding diagnosis was provided by the participants themselves. In paper II, this was 
based on inclusion criteria in each study. In papers III and IV, participants were to 
provide a certificate from their neurologist or excerpts from their hospital record 
confirming the diagnosis. A plenitude of methods was used to assess participants’ 
function throughout papers I, III and IV. The following paragraphs describe those 
assessments of greatest importance for the comprehension of this thesis.  
4.4.5.1 Balance 
In papers I, III and IV, balance was assessed using the Mini-BESTest. This is a clinical 
test covering four components of balance: anticipatory postural adjustments, reactive 
postural control, sensory integration and dynamic gait. It ranges from 0 to 28 points 
with higher scores indicating better balance performance.4 Psychometric evaluation has 
shown that this tool has good inter-rater and test-retest reliability in PD. Evaluations of 
agreement, however, have shown large measurement errors, especially in the reactive 
postural control subcomponents.117   
Balance confidence was measured with the help of the Activities-specific Balance 
Confidence scale (ABC), a self-report questionnaire where participants subjectively 
rated their confidence in performing various ambulatory activities without falling. More 
specifically, participants rate to what extent they feel confident in performing 16 
activities on a scale from 0 to 100.118 The ABC scale has been used extensively in PD and 
has very good internal consistency and test-retest reliability in this population.119 
4.4.5.2 Single and dual task gait  
Temporal and spatial gait parameters during single and dual task walking was captured 
using the electronic walkway system GaitRiteÓ (CIR Systems, Inc., Haverton, PA, USA). 
A distance of three meters at both ends of the walkway was used for acceleration and 
deceleration distances, thereby ensuring steady state walking.120 Participants walked at 
self-selected usual speed during single and DT conditions. For paper III, only gait speed 
was reported, whereas in paper IV 16 gait variables were calculated and reported. These 
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16 gait variables are the same as those described in the background, paragraph 2.2.2 
Constructs of balance and gait. Asymmetry variables were calculated as the absolute 
difference between left and right leg, whereas variability variables were calculated in 






For the secondary aims of paper IV, two gait variables were chosen: gait speed and step 
time variability. Speed, which is a global measure of gait,122 is perhaps the most 
intuitively interpretable gait parameter, whereas step time variability on the other is 
interesting, as it has previously been used as a surrogate marker for both fall risk123 and 
gait automaticity.124 Step time variability has also been suggested to be independent of 
gait speed, and perhaps more reliant on balance-control mechanisms.125 
 In paper III, two different cognitive DTs were compared: the auditory Stroop task126 and 
an n-back task (two-back).127 Based on the results of the feasibility investigation in paper 
III, we decided to continue using the auditory Stroop task for the large scale RCT (and 
thereby also for paper IV of this thesis). During the DT condition, participants were 
introduced to the auditory Stroop, which is a task addressing set shifting and inhibition. 
It is both valid128 and reliable129 for DT gait assessment in PD. During this task, 
participants used wireless headphones through which they were presented with the 
Swedish words for “high” or “low” in congruent or incongruent high and low tones. 
Participants were instructed to respond verbally to the corresponding tone as quickly 
as possible. The auditory Stroop task was performed both as a single (in a seated 
position) and DT (during walking), and a randomization process decided which 
condition came first. In the DT, walking participants were instructed to pay equal 
attention to walking and the auditory Stroop task. Reaction times (RT, beginning of 
stimulus to beginning of response) on the auditory Stroop task was analysed using 
MATLAB (R2017b).130  See Figure 5 for example of audiofile as analysed in Matlab. The 
script provided mean reaction times as well as standard deviation of reaction times 
(SDRT); the latter was used as a measure of intraindividual variability.  
Perceived walking difficulties were assessed using the Walk-12 scale, a questionnaire of 





Figure 5. Example of audiofile, with reaction times (RT).  
4.4.5.3 Motor function and disease severity 
In paper I, motor function was assessed using the Unified Parkinson Disease Rating 
Scale (UPDRS), whereas the revised version MDS-UPDRS was used in papers III-IV.133 
In full, both scales contain four parts pertaining to motor and non-motor experiences 
of daily living, a motor examination and a section pertaining to motor complications. 
Although restructured in order to improve clarification, the later version correlates 
highly with the original scale (total score r=0.96), thereby showing a strong concurrent 
validity.3 This thesis mainly focuses and reports on part III, the motor examination, 
which is also strongly correlated between the UPDRS and the MDS-UPDRS (r=0.96).  
All parts of MDS-UPDRS have proven to have high internal consistency, with part III 
(motor part) having the highest (Crohnbach´s alpha=0.93).3   
As part of the UPDRS and MDS-UPDRS scales, participants are also scored on the H&Y 
scale, a five-point disease rating scale ranging from 1, meaning minimal or no disability, 
to 5, where the person is confined to bed/wheelchair unless aided.1 The H&Y scale was 
used during eligibility screening for studies I, III and IV, and will be used as a measure 
of disease severity in this thesis.  
4.4.5.4 Markers of neuroplasticity 
Papers II and III evaluate different aspects of exercise-induced neuroplasticity. Where 
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III is instead on the feasibility aspects of using neuroplastic outcomes to evaluate the 
HiBalance program. 
As the aim of paper II was to compile all available published evidence to date, we were 
interested in any outcome measure of neuroplasticity. We have divided them into three 
subdomains: neurochemical, brain function and brain structure. For a full list of methods 
used within each subdomain, see paper II, Table 1. 
In paper III, participants underwent structural MRIs, resting state fMRIs and two task-
based fMRI scannings before and after the intervention period. For this assessment, a 
Philips Ingenia CX 3 Tesla MRI scanner was used. In an attempt to investigate the same 
abilities as during gait analysis we designed the task fMRI sequences to be one single 
task (motor task, using index and middle fingers on both hands to push buttons) and 
one DT (similar motor task as in single, but with added cognitive task where 
participants counted plus signs).  
Levels of brain-derived neurotrophic factor (BDNF) in plasma was measured at two time 
points in paper III. Blood samples were collected at each training site before the first 
and last training session by a registered nurse.  
4.4.5.5 Cognitive function 
As part of the eligibility screening for studies I, III and IV, global cognitive function was 
assessed using MoCA.5 In studies III and IV, participants were further examined with a 
neuropsychological test battery. This battery took in a total of 60-70 minutes and 
targeted four cognitive domains: executive function, attention/working memory, 
episodic memory and visuospatial functions. For paper IV the neuropsychological test 
battery was used in order to classify participants as PD non-MCI or PD MCI, according 
to the Movement Disorder Society task force level II category.134 See paper IV for a 
detailed description of the classification process. 
4.4.5.6 Well-being 
Quality of life and health status was measured using either PD-specific or -generic 
questionnaires. Parkinson Disease Questionnaire -39 (PDQ -39) is an instrument that 
covers the impact that PD has on various aspects of both functioning and well-being.135 
The scale has good content and construct validity, as well as good internal consistency 
for the scale total (Crohnbachs alpha 0.84-0.94).136 In the papers included in this thesis, 
only the summary index, a score derived by dividing the sum of the subscores by eight 
(the total number of subdomains), of the PDQ -39 is reported.  
Further, participants completed the Euroqol 5 dimensions (EQ5D),137 a widely used 
generic instrument where the respondent rates his or her problems with mobility, self-
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care, and usual activities, as well as pain and anxiety/depression, on a three-level scale. 
The respondent further rates his/her health on a scale from 0, meaning the worst health 
imaginable, to 100, meaning the best health imaginable. In the papers included in this 
thesis, only the last part (health rating) is reported. 
4.4.6 Feasibility outcomes 
4.4.6.1 Process feasibility 
As already mentioned, the focus of paper III was not on the efficacy of the intervention, 
but on the feasible aspects of our proposed RCT design. With regards to feasibility of 
pre- and post-assessment sessions we focused on the experimental setup of those 
methods not previously conducted in the BETA-PD project. Several aspects of the DT 
gait assessment for paper III demanded attention. As described in paragraph 4.4.5.2 
Single and dual task gait, we compared two different types of cognitive DTs (auditory 
Stroop and n-back) during walking with the intention of choosing one of them for the 
future RCT. Whereas some feasibility aspects of DT gait lent themselves to descriptive 
explorations, such as accuracy (% correct answers), others, such as participants’ ability 
to understand instructions, were evaluated in a more pragmatic manner through 
discussions within the research team. The brain imaging session was evaluated both by 
means of pure image quality, but also to patient-related measures/symptoms such as 
pain/discomfort, drowsiness, diplopia, etc. Lastly, we monitored participants’ 
compliance with blood sampling and noted whether any participants refused this type 
of examination.  
Attendance at each training session was reported by the trainers. Compliance with the 
home exercises was monitored using a simple diary where participants reported 
whether or not they had performed the exercises each week. Participant acceptance of 
the HiBalance training and the HiCommunication training was further explored using 
anonymous questionnaires after the last training session. Here, participants answered 
questions relating to whether they felt that the intervention had improved (or 
worsened) symptoms related to balance, voice/speech or other symptoms, and whether 
they had experienced any side effects such as pain or fatigue from the training sessions. 
They also rated to what extent they would recommend this type of training to other 
people with PD.  
Assessors of physical performance were to be blinded as to which intervention 
participants were allocated. The blinding process was evaluated with a questionnaire 
inspired by Minns Lowe et al.,138 in which the assessors after the last post-assessment 
session stated whether or not they knew which group the participant had taken part in, 
and whether this was a guess or if the participant had in fact revealed it. 
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4.4.6.2 Scientific feasibility 
Adverse events during the group training sessions were noted by the trainers, whereas 
adverse events during home exercises were noted by participants.  
Trends in treatment response were explored descriptively, with a specific focus on 
physical performance, well-being, executive function and voice intensity.  
4.4.7 Interventions 
4.4.7.1 Paper II 
Various types of physical exercise interventions were conducted in the trials in paper II, 
including exercise bike, treadmill training, balance training, motor rehabilitation, 
multidisciplinary rehab, improvisational dance and gait training. 
4.4.7.2 Paper III 
The intervention in paper III was the HiBalance training. The efficacy and effectiveness 
of this program was evaluated by our research group previously.82, 85 The HiBalance 
program consists of highly challenging balance exercises targeting four areas of balance: 
sensory integration, anticipatory postural adjustments, motor agility and stability 
limits. Exercises were performed in a group setting twice a week for ten weeks in an 
increasingly challenging manner. Exercises were primarily progressed by adding 
cognitive and/or motor DTs. Participants were also instructed to perform a home 
exercise program (HEP) that focused on functional aerobic and strength exercises once 
a week. 
The active control group intervention was developed and tested for the first time in 
paper III. Participants in the control group received speech and communication 
training, and the program was subsequently called HiCommunication. Exercises here 
instead focus on four areas important for communication in PwPD: voice intensity, 
articulatory precision, word retrieval and memory. Participants were also instructed to 
perform a HEP that focused on voice and speech function once a week.  








Descriptive data in this thesis was analysed using IBM SPSS Statistics for Macintosh, 
Version 25.0 and 26.0 (Armonk, NY: IBM Corp.) The overall approach presents mean 
and standard deviations for normally distributed data, but median and interquartile 
range (or range) for non-normally distributed data and small samples as appropriate 
throughout all studies. Normality was assessed with kurtosis and skewness values, 
Shapiro-Wilks values and by visual inspection of QQ-plots and histograms. Specific 
statistical tests are summarized in Table 3. 
Table 3. Descriptive and inferential statistical methods used in the thesis. 
Statistics Paper I Paper II Paper III Paper IV 
Descriptive      
Counts • • • • 
Percentages  • • • 
Range •    
Mean (and SD) • •  • 
Median (and IQR, range)   • • 
Inferential      
Confidence intervals  •  • 
Hedges’ g  •   
Wilcoxon signed rank test    • 
Single sample t-test    • 
Pearson’s correlation coefficient    • 
Univariate linear regression    • 
Multiple linear regression    • 
Abbreviations: IQR, interquartile range; SD, standard deviation 
4.5.1 Paper I 
Interview transcripts were analysed using content analysis, a systematic method of 
capturing central themes from text.139 All transcripts were read repeatedly, after which 
meaning units were identified. The meaning units were then coded in several cycles, 
where they were first assigned descriptive information codes during the first cycle and 
pattern codes during the second cycle.140 Conformability of the analysis process was 
ensured through a series of team debriefing meetings where all authors discussed 
coding and categorization. All authors were also involved in developing and refining 
subthemes, main themes and the overarching theme.  
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4.5.2 Paper II 
Upon inclusion in the review, all studies were assessed based on research quality. The 
critical appraisal method chosen was the 27-item Downs and Black checklist, which was 
modified for the purpose of this review. The Downs and Black checklist ultimately 
provides an overall index by including the following domains: reporting, external 
quality, internal validity bias and internal validity confounding.141 An overall quality 
index grade was then applied according to the suggestion by O´Connor et al: excellent, 
good, fair or poor.142  
Two types of syntheses were conducted in paper II, a narrative (qualitative) where all 
included studies within each outcome subdomain were included, as well as a meta-
synthesis (quantitative) within the neurochemical subdomain. The narrative synthesis 
reported the direction of change (positive, negative or absence) within each 
neuroplastic outcome subdomain. For the meta-synthesis, only the neurochemical 
subdomain was included, as this was the only subdomain that provided aggregable and 
comparable outcome data. The Meta-essentials workbook 4 was used, in which effect 
sizes were generated using a random effects model.143  
An overall level of evidence as to whether exercise can induce neuroplasticity in PwPD 
was assessed using the GRADE method.144 After having set an initial level of evidence 
based on a judgement of paper phase, the following factors were considered for further 
downgrading: study limitations, inconsistency, indirectness, imprecision and 
publication bias. Lastly, an overall four level of evidence was set: ++++ (high), +++ 
(moderate), ++ (low), or + (very low). 
4.5.3 Paper III 
Due to the small sample size (n=7 in the HiBalance group and n=6 in the 
HiCommunication group), no inferential statistics were applied in paper III. All 
demographic data and clinical characteristics at baseline, as well as trends in treatment 
response, are therefore reported in median and range. Treatment response i.e. changes 
in physical performance measures (balance and gait), well-being, executive function 
and voice intensity, from pre- to postintervention, was calculated as median differences 
in respective outcomes. 
The DT effect on gait speed and accuracy on respective cognitive task was calculated as 
suggested by Kelly et al.145 
#12(%) = 	#4(5	6(78 − "*+:5-	6(78"*+:5-	6(78 	× 100 
Feasibility outcomes with a numerical value, such as attendance rates and blinding 
rates, were compiled and reported descriptively. Recruitment rate was calculated as the 
 
 33 
number of people eligible for inclusion divided (n=13) by the number of people 
reporting interest in participating (n=42). Closed questions in both the MRI feasibility 
questionnaire and the intervention follow-up questionnaire were coded and collated. 
Open questions were instead categorized as appropriate, but not coded.  
4.5.4 Paper IV 
The main aim of the study was to explore DT effects on all 16 gait parameters, as well as 
three outcomes on auditory Stroop (accuracy, reaction time and SDRT). The main 
outcome, the DT effect, was calculated as suggested by Kelly et al.145; see paragraph 4.5.3 
Paper III for equation. To assess whether there was a significant difference in 
performance between single s DTs, a Wilcoxon signed rank test was conducted (non-
parametric statistics were used, as many of the gait variables were non-normally 
distributed). 
For the secondary aims, unadjusted and adjusted linear regression were applied. Dual 
task effects (on gait speed, step time variability and cognitive performance) were used 
as dependent variables. Potential factors associated with DT effect variables were 
selected first on clinical reasoning, and thereafter on correlation (p<0.2) in univariate 
linear regression. Multicollinearity cutoff was set at r>0.6. Independent variables were 
entered into the regression models using backward selection. For more information on 
handling of univariate and multivariate outliers, see manuscript for paper IV.  
Lastly, prioritization was calculated by subtracting the DT effect on gait variables speed 
and step time variability from the DT effect on cognitive performance. A negative value 
thus indicated gait task prioritization (posture first strategy), and a positive value 
indicated cognitive task prioritization (posture second strategy). In order to determine 
if the mean prioritization value was significantly different from zero, a single sample t-
test was run. Univariate linear regression was used to assess the potential of group 
differences between the PD MCI group and the PD non-MCI group, with regards to the 
DT effect variables and prioritization (DT effect variables as dependent variable and 
cognitive status as independent variable). These models were also rerun adjusted for 






5.1 PERCEPTIONS OF BALANCE AND GAIT – PAPER I 
From the thematic analysis of the interviews in paper I emerged 13 subthemes that 
represented five main themes: Remaining in control over the body; Adapting behavior 
to deal with uncertainty; Directing focus to stay one step ahead; Resilience as a defence; 
and Exercise beliefs and reservations. Together, these main themes formed the 
overarching theme Focus and determination to regain control over shifting balance; see 
Figure 6 for an overview.  
 
 
Figure 6. Overview of the overarching theme, main themes and subthemes (italics) 
emerging from the thematic analysis 
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5.1.1 Remaining in control over the body 
Participants described the concept of balance in terms of being able to control one’s 
equilibrium through a combination of automatic and voluntary processes. To have 
equilibrium was described as being in an effortless state where one did not have to plan 
for balance challenging movements. Having “good” balance meant feeling a sense of 
normalcy, where one wasn´t mistaken for being under the influence of alcohol and 
where movements could be performed in a “normal” manner.     
5.1.2 Adapting behavior to deal with uncertainty 
Having impaired balance repeatedly meant having to adjust or even quit doing activities 
one would like. This connection between balance as a physical function, and the 
consequences it had on one’s sense of freedom and independence, meant balance was 
also talked about in relation to mental well-being and the interplay between body and 
mind.  
5.1.3 Directing focus to stay one step ahead 
Participants described becoming more aware of and careful in balance challenging 
situations. Not only were they more thoughtful when planning their movements, but 
also more attentive while performing them. They expressed having to concentrate on 
one task at a time and put an increasing amount of effort into it so as not to fall. One 
recurring strategy described was self-talk as a way to communicate with one’s body 
when performing goal-directed actions. 
5.1.4 Resilience as a defence 
Even though having impaired balance forced participants to change some aspects of 
their everyday life, they did express a determination not to refrain from activities they 
enjoyed or from spending time with loved ones. Not adapting too much and not feeling 
sorry for themselves also meant that they did not let the diagnosis or balance 
impairment define who they were.  
5.1.5 Exercise beliefs and reservations 
Belief in exercise varied. Some used exercise or physical activity as a means to take their 
mind off of the disease. Others expressed exercise as necessary symptom relief, and 
some also believed that challenging activities was positive for the brain. Not all, 
however, believed that exercise could improve symptoms. Some believed that since the 
brain is affected by PD, symptoms were less likely to be managed with exercise. Others 
simply had previously had unsatisfying results from exercise, which had led to doubt. 
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5.2 EVIDENCE FOR EXERCISE-INDUCED NEUROPLASTICITY – PAPER II 
The final result of our extensive database searches was that a total of 13 articles were 
included in the systematic review. These studies had been performed in various 
countries (Brazil, Canada, Germany, Israel, Italy, Spain and USA) and settings (three 
inpatient and ten outpatient). The sample sizes were small, rendering a total of 151 
intervention group participants and 63 controls. Methods used to explore 
neuroplasticity were divided into three domains and included neurochemical (plasma 
and serum levels of brain-derived neurotrophic factor, as well as BDNF-TrkB signalling), 
brain function (fMRI, EEG, PET and TMS) and brain structure (MRI). Quality 
assessment according to the modified Downs and Black checklist revealed that a 
majority (nine) of these studies were of “fair” quality, while three were of “poor” quality, 
and one was rated as “good” quality.  
5.2.1 Narrative synthesis 
The narrative synthesis revealed positive effects of exercise on neuroplastic changes 
within the brain function and brain structure domains. Within the neurochemical 
domain, results were less clear, with three studies showing positive effects and one 
study no effects. See Table 4 for narrative synthesis. 
5.2.2 Meta-analysis 
Three studies within the neurochemical domain provided aggregable data and were 
therefore synthesized. Due to missing r-values, all studies were assigned the same r-
value, and analysis was repeated three times with different values (0.25, 0.60 and 0.80). 
Overall effect sizes ranged from 0.91 to 1.84, but the confidence intervals included zero 
in all analyses, which indicated that these were non-significant. See paper II, Figure 2 
for meta-analyses and forest plots. 
5.2.3 Overall evidence synthesis 
The GRADE analysis revealed the level of evidence in exercise-induced neuroplasticity 









Table 4. Narrative synthesis of neuroplastic outcomes from pre to post intervention. 
Reference Method  
Specification of signaling type or 




Angelucci et al146 Serum BDNF  — 
Fontanesi et al147 TrkB signalling 
in lymphocytes pY-TrkB (145 kDa) ↑ 
  pY-TrkB (95 kDa) — 
  NR1 ↑ 
Frazzitta et al148 Serum BDNF  ↑ 
Zoladz et al149 Serum BDNF   ↑ 
Brain function 
Batson et al150 fMRI Connection between anterior and 




  Connection between basal ganglia 
and premotor cortex 
↑ 
 
Duchesne et al151 fMRI Temporal lobes ↑ 
  Left ventral striatum ↑ 
  Left hippocampus ↑ 
  Cerebellum (lobules 8 and 9 
bilaterally, and right crus) 
↑ 
 
Maidan et al152 fMRI Middle temporal gyrus ↑ 
Shah et al153 fMRI Connection between active motor 
cortex and ipsilateral thalamus 
↑ 
 
Carvalho et al154 EEG No significance given to area ↑ 
Fisher et al111 TMS  CSP-duration in both hemispheres ↑ 
Fisher et al155 PET Dorsal putamen ↑ 
del Olmo et al156 PET Right cerebellum ↑ 
  Right parietal lobe ↑ 
    Right temporal lobe ↑ 
Brain structure 
Sehm et al157 MRI Right hemisphere of cerebellum** ↑ 
*Change in direction as interpreted by respective authors as to whether the change in 
neuroplastic marker was positive (↑) or unchanged (—). No negative changes were 
reported. 
**As compared to healthy control group 
Abbreviations: BDNF, Brain Derived Neurotrophic Factor; pY, phosphotyrosine; TrkB, 
Tyrosine receptor kinase B; fMRI, Functional Magnetic Resonance Imaging; EEG, 
Electroencephalogram; TMS, Transcranial Magnetic Stimulation; CSP, Cortical Silent 




5.3 FEASIBILITY OF EXPLORING EXERCISE-INDUCED NEUROPLASTICITY – PAPER III 
5.3.1 Process feasibility 
A total of 42 people responded to the advertisement and were screened for eligibility. 
Fourteen could be included, but one person chose to withdraw before randomization, 
rendering a recruitment rate of 31%. Of the 26 excluded during the initial telephone 
screening, 13 were excluded based on brain imaging safety reasons (incompatible 
implants or claustrophobia). See Figure XX for flow chart, and paper III, Table 3 for 
demographic and clinical characteristics of the included participants. 
 
Figure 7. Flowchart of the study process in paper III. 
Participant acceptability of both training groups as well as the three assessment sessions 
pre- and post-training, was overall good based on attendance rates (84.3% and 89.0%, 
respectively), home exercise diaries, follow-up questionnaires and MRI questionnaires. 
Brain imaging sessions brought forth a number of unforeseen challenges. Although a 
rigorous screening protocol was set in place, it turned out that two people could still 
not undergo the MRI examination because they reported anamnestic information of 
metal splinters in their eyes right before the session. With a number of participants that 
Lost to follow‐up (n=1)
Discontinued intervention due 
to other medical issues (n=1)
Allocated to HiCommunication (n=6)
 Received allocated intervention (n=6)
Lost to follow‐up (n=0)
Allocated to HiBalance (n=7)





 Not meeting inclusion criteria (n=2)
Declined to participate (n=1)
Assessed for eligibility (n=16)
Enrollment
Excluded (n=26)
MRI incompatible implants (n=11)




Screened prior to eligibility assessment (n=42)
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were able to undergo brain imaging, we encountered issues that affected performance 
during task fMRI such as sleepiness, diplopia, physical discomfort or emotional distress. 
Structural images (T1) were of acceptable to good quality, and head motion was deemed 
to be at an acceptable level. Participants complied with blood sampling, but due to 
logistical problems several post-intervention blood samples were unfortunately lost. 
Blinding was successful in a majority of cases for one of the assessors but broken in half 
of cases for the other assessor.  
5.3.2 Scientific feasibility 
The focus when exploring trends in treatment response was on physical performance, 
well-being, executive function and voice intensity. These results should, however, be 
interpreted with caution, as no inferential statistics were applied and are reported 
descriptively as median difference only. No improvement in balance performance as 
measured by Mini-BESTest was shown in either group. There was a median increase of 
0.05m/s in usual gait speed in the HiBalance group, whereas there was no change in the 
control group. Health-related quality of life as measured by the PDQ -39 summary index 
improved (median decrease of 8.4%) in the HiBalance group but remained unchanged 
in the control group (median increase of 1.7%). Results on tests of executive function 
were ambiguous with some results in favour of the HiBalance group and others in favour 
of the control group. Lastly, voice intensity improved in the control group (median 
increase in sound pressure level by 2.5%) but remained unchanged in the HiBalance 
group (median difference of 0.0%).  There were two non-injurious falls during the group 
training sessions, and two non-injurious falls were reported during performance of 
home exercises in the HiBalance group.  
5.4 DUAL TASK PERFORMANCE – PAPER IV 
A total of 93 participants were included in the analysis for the primary purpose of paper 
IV, and 65 of these were then further analysed for secondary purposes. See paper IV, 
Table 2 for descriptive characteristics of included participants. 
5.4.1 Dual task effects on gait and cognition 
Different domains of gait were diversely affected when adding the cognitive DT. 
Whereas all variables within the pace and variability domains exhibited DTCs, there 
was no significant deterioration of variables within the asymmetry domain. Three 
outcomes concerning cognitive performance were assessed. Accuracy was not affected 
by doing the task during walking as opposed to sitting, whereas reaction times increased 
significantly and a measure of intraindividual variability, i.e. standard deviation of 
reaction time (SDRT), revealed high DT costs. See Figure 8 for a compilation of DT 
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effects on all variables within each gait domain as well as on the auditory Stroop task. 
For absolute values of single and DT performance, see paper 4, Table 3.  
 
Figure 8. Overview of dual task effects on gait variables and the auditory Stroop task. 
Asterisks indicate those variables where the difference in performance between single 
and dual task was significant (** p<0.001, *p<0.05). 
5.4.2 Factors predicting dual task performance 
Three different models with different DT effect variables as dependent variables were 
carried out. All models attained statistical significance (p<0.05). Together, the 
independent variables cognitive status (PD MCI or PD non-MCI) and Timed Up and Go 
cognitive (TUG-cog) predicted 20.9% and 15.7% of the variance in DT effect on gait 
speed and DT effect on step time variability, respectively. The same independent 
variables with the addition of MDS UPDRS subscore I could predict 13.9% of the 
variance in DT effect on cognition. 
5.4.3 Role of cognitive status in dual task walking 
The participants who were classified as having PD MCI had significantly higher DTC on 
both gait speed and step time variability compared to PD non-MCI (mean difference 
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8.1% [95% CI 13.6 - 2.6; p=0.005] and 30.4% [95% CI 51.3 - 9.5; p=0.005], respectively). 
These results remained statistically significant after adjusting for sex and age (7.8%, 95% 
CI 13.7 - 2.0; p=0.009, and 32.6%, 95%CI 54.7 - 10.4; p=0.005, respectively). There was 
no across-group difference with regards to DT costs on cognitive performance 
(p=0.108). Further analysis revealed that cognitive status influenced prioritization 
during DT walking. PwPD in the non-MCI group prioritized gait speed over cognitive 
performance (p=o.003), while the PD MCI group instead prioritized cognitive 
performance over gait speed (p=0.044). The same pattern of prioritization with regards 
to step time variability was seen in the PD MCI group, whereas in the PD non-MCI 
group there was a lack of prioritization of one task over another. Across group analysis 
of both prioritization variables revealed statistically significant differences between the 
groups, supporting the finding that these populations prioritize differently. See Fig. 9 
for scatter-graphs of DTE on gait speed and step time variability and on cognitive 
performance for PD non-MCI and PD MCI, respectively. 
 
Figure 9. Patterns of dual task effects (DTE) between cognition and gait speed (upper 
two graphs) and step time variability (lower two graphs) for PD non-MCI (left) and PD 
MCI (right). In each graph the upper left quadrant indicates a gait-priority trade-off, the 
lower right quadrant a cognitive-priority trade-off, the upper right quadrant a mutual 
dual task benefit and the lower left quadrant a mutual dual task cost. 
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6.1 SUMMARY AND DISCUSSION OF MAIN FINDINGS 
This thesis intended to explore perceptions and performance of balance and 
gait in PwPD. It further aimed to establish the current evidence for exercise-induced 
neuroplasticity and to evaluate feasibility aspects of investigating exercise-induced 
neuroplastic changes among PwPD. The results in this thesis describe how PwPD 
perceive the concept of balance as having multiple layers, both pertaining to physical 
equilibrium and to the interplay between body and mind. Having poor balance touched 
many aspects of everyday life, physically, emotionally and socially. Balance was 
described in the context of control, and how living with impaired balance in a sense 
meant losing control in everyday life. In PwPD, all aspects of gait except asymmetry was 
worsened when walking with an added task. Dual task walking appeared to be more 
compromised in people with PD MCI compared to PD non-MCI as shown in higher DT 
costs on gait speed and step time variability. Analysis of prioritization revealed that PD 
MCI consistently used a posture-second strategy whereas PD non-MCI tended to use a 
posture-first strategy. Current evidence for neuroplasticity in PD suggests that both 
brain structure and function can experience a positive alteration as a result of physical 
exercise, whereas studies on neurochemical adaptations points in disparate directions. 
The overall level of evidence for exercise-induced neuroplasticity in PwPD is still 
however very low. A proposed design for a large scale RCT investigating whether ten 
weeks of highly challenging balance training has the ability to induce neuroplastic 
changes in PwPD proved feasible and acceptable. Adjustments to the experimental set-
up of the MRI paradigm, DT gait analysis and the blinding process will improve the 
design further.   
6.1.1 The meaning of balance 
During the interpretative stage of the interview analysis, it became clear how the 
meaning of balance was inherently intertwined with concepts of control. Whereas 
“good balance” mainly involved the ability to stay upright, impaired balance was instead 
talked about in a sense of losing control of everyday life, and a reduced sense of freedom 
and independency. In other words, balance was perceived both as bodily equilibrium 
and as the interplay between body and mind. Participants described how disease 
progression had led to a perceived loss of control and a feeling of being restricted from 
engaging in life as one would have wanted to, a description supported by other 
qualitative inquiries in PD.158  Being able to uphold meaningful interactions and 
activities are two important factors for maintaining a sense of normalcy and social 
identity, but this can be challenging in PD.159 Sustaining ones self-identity when being 
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diagnosed with PD entails making new meanings and taking  action based on these 
meanings.159 This thesis was particularly focused on the meaning of balance, and 
interviewees described various ways by which they struggled both physically and 
psychologically to maintain a sense of normalcy despite their impaired balance. 
Through this process of reconstructing life a person with a chronic illness can once 
again gain control over their body and their life.160 The term locus of control (LOC) was 
coined by Rotter almost six decades ago, and concerns whether a person believes that 
an event is contingent on their own actions (internal), or luck, chance or a powerful 
other (external).161 In PwPD, the belief that health is controlled by external factors is 
higher than in healthy controls.162 As the disease progresses, the less likely PwPD are to 
believe that health lies within their own control. Within the context of our findings, we 
did not pose questions as to how feelings of control had changed over time, but we did 
ask whether they believed that they could affect their balance. Some participants 
expressed that they believed that by exercising and staying active they could influence 
their balance, whereas others believed that external factors such as medication or 
surgery was the sole remedy. In our sample, participants with negative previous 
experiences of exercise tended to express less belief in their own ability to affect balance. 
Given that exercise and physical therapy is an important part of managing PD 
symptoms it is of utmost importance that we understand the process by which PwPD 
initiate and maintain exercise behavior. According to the Common-Sense Model of Self-
Regulation, this process is intrinsically dependent on our beliefs in whether our 
symptoms can be cured or controlled.163 If we believe that an action leads to a desired 
result, we are more likely to initiate it.164 Communication regarding previous exercise 
experience and on beliefs in anticipated results may be key to motivating our patients 
to initiate rehabilitation programs.    
6.1.2 Walking while performing a secondary task 
Several of the participants who were interviewed for this thesis described using a form 
of self-talk during balance-challenging situations. This was a strategy to stay focused on 
the task at hand, while at the same time managing and anticipating the next step. 
Walking was not relaxed, but instead required an increasing amount of effort. In PwPD, 
automatic movements, such as walking, become increasingly difficult as a result of 
dopamine loss in the basal ganglia. Instead of relying on automaticity, they need to exert 
to strategies that involve the use of goal-directed movements.36 In other words, the self-
talk as described in the interviews, allowed them to circumvent  habitual, or automatic, 
walking behavior and perform complex walking and balance tasks in a goal-directed 
mode instead. It has been suggested that this loss of automaticity may be particularly 
evident during DT walking, and that the cost that performing a second task 
simultaneously, has on walking can be used as a proxy measure for attention and 
automaticity.165 Findings from our gait analysis showed that the introduction of a 
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cognitive task to be performed while walking had significant costs across all domains of 
gait except asymmetry. Onset symptoms in idiopathic PD are commonly unilateral in 
nature which may lead to gait asymmetry being more prominent early in the disease 
process.166 In paper IV we excluded those with unilateral symptoms, i.e. H&Y 1, which 
could explain why no DT effects were found in the asymmetry domain. Interestingly, 
within the variability domain there were not only significant DT costs across all 
variables, but compared to the other gait domains, they were also the highest. When 
gait shifts from an automatic mode into being more consciously controlled, it has been 
suggested that variability may be particularly affected.42 The difficulties with 
consciously controlling variability in gait have been highlighted both in healthy 
people,167 and in PD,168  where studies have shown that despite instructions during DT 
walking to specifically concentrate on “consistent” or “safe” walking, variability stayed 
unchanged or even worsened. In paper IV performance of the cognitive task also 
deteriorated while walking, something which was shown by significant costs on reaction 
times and intraindividual variability (SDRT). Accuracy was not affected when walking 
and was high both in single and DT conditions. This may have reflected a ceiling effect. 
As part of the findings from paper III, we did shorten the interstimulus intervals in order 
to reduce the risk of such a ceiling effect for the larger RCT (from which baseline data 
have been used for paper IV) and given the range in RT it would have been difficult to 
shorten them even more. One thing to consider though is that we did not adapt the 
difficulty level of the auditory Stroop task to each individual, something that could be 
considered for future trials in light of these results.  
Subgroup analysis revealed that cognitive impairment intensified DT costs further, as 
shown by greater proportional reduction in gait speed and increased step time 
variability in the PD MCI group, compared to the PD non-MCI group. This was an 
interesting finding as other studies comparing these groups either found no 
differences,69 or only found differences during the OFF stage of the medication cycle.169 
A possible reason for the discrepancy between findings in the current thesis, and 
previous research may lie within differences in the PD MCI criteria used. We utilized a 
comprehensive neuropsychological test battery, and classified participants according to 
a level II criteria as suggested by the MDS task force,134 whereas it is not unusual within 
this research area to use a less comprehensive and less varied test battery, or simply a 
cut-off from a single test of global cognition. Identifying cognitive impairment in PD is 
complex, something recently highlighted in a study in which up to 45% of PwPD who 
scored high (≥26) on MoCA actually exhibited cognitive decline on  two or more 
neuropsychological tests.170 This group would have been classified as PD MCI according 
to the MDS task force level II criteria.134 By using different diagnostic criteria, research 
groups may therefore end up with groups who are, by definition, not comparable when 
it comes to PD with and without MCI. If the end goal is to synthesize data between 
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studies and provide clinicians with recommendations, a prerequisite is to make sure we 
draw conclusions from groups of comparable cognitive function.  
This thesis also evaluated whether prioritization differed according to cognitive status. 
Indeed, we found that participants with PD MCI consistently prioritized the cognitive 
task over gait (posture-second strategy), whereas the PD non-MCI group tended to 
prioritize gait over cognitive performance (posture-first strategy). Once validated in 
other studies, such information may provide us with important clues as to whether 
interventions should be tailored differently according to cognitive status. It may also 
have a direct clinical application with regard to fall risk assessment as it has been 
suggested that using a posture-second strategy may predispose of falls.53 Although the 
value of evaluating DT performance as part of a fall-risk assessment has been questioned 
previously,171 several prospective studies have found cognitive impairment to be a main 
source of fall-risk in the PD population.172-175 Both the European and the Swedish 
guidelines for physical therapy in PD recognizes the importance of being aware of any 
cognitive impairments when assessing and choosing an intervention in clinical care.176, 
177 As physical therapists are seldom trained in cognitive assessments, the European 
guidelines recommend that such information should be provided by a physician.177 A 
survey study among Swedish physical therapists however revealed that collaborations 
with other professionals including physicians depended greatly on work setting .178 Also, 
comprehensive neuropsychological test batteries such as the ones used in this thesis are 
seldom performed as a part of standard  physical therapy rehabilitation. Given the 
complexity and range of cognitive impairments in PD and the consequences these may 
have for the person in question, it may however be time that we advocate for more 
detailed cognitive evaluations in clinical care.  
6.1.3 Exploring exercise-induced neuroplasticity 
Some of the interviewees in this thesis voiced opinions on how exercise was good for 
the brain, and even expressed positive thoughts on the brain’s capacity for regeneration. 
Others were more skeptical, viewing changes to the brain as something that were out 
of their control. Our interviewees diverse thoughts on this topic also mirror the current 
evidence for exercise-induced neuroplasticity in PD. Although a majority of the studies 
published to date point to an ability of brain structure, brain function and levels of 
BDNF to alter in a positive direction after a period of physical exercise in PwPD, much 
work still remains in this research field. Researchers who endeavor to study the effects 
of exercise on neuroplasticity are however faced with some fundamental challenges. 
One is the question of causation.179 Even if we can show that a certain type of exercise 
improved some measure of behavior, and that  behavior was correlated to some change 
in brain structure, we still don’t know exactly what caused these structural changes. 
However in order to improve neurorehabilitation through interventions that are 
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designed to facilitate neuroplastic changes, causation may not matter.179 It does 
however speak to the importance of evaluating behavioral changes, as well as 
correlating them with the neuroplastic outcomes, something not always done in the 
studies included in paper II. The very point of exploring behavioral and neural signals 
that drive neuroplasticity is to be able to augment functional outcome.8 Without a 
measure of behavioral change to correlate with, information on changes in neural 
structure and function after a period of training is rather uninformative from a 
neurorehabilitative standpoint. In an ideal setting, the therapist would have 
information on both impaired and preserved abilities at both the behavioral and neural 
levels. The therapist could then create a strategy for rehabilitation which involved 
recruiting residual brain structure and function to drive behavioral improvement.8 We 
need an intervention that adheres not only to basic training principles (specificity, 
progressive overload and varied practice)83, 84 but also to key elements that harness 
neural activity (intensity, repetition and timing).8 The methods used to explore 
neuroplastic changes should not only be found acceptable by participants, but also 
cover behavioral changes complemented by one or more levels such as molecular or 
neural structure and function.179 This ideal setting is however far from how 
rehabilitation in PD or other neurological populations is currently conducted, and many 
questions remains to be answered before such implementation can take place.  
Given the complexity and need for multidisciplinary involvement when conducting 
research on exercise-induced neuroplasticity it is highly important to find feasible 
methods. Conducting a pilot trial in preparation of a large scale RCT provides an 
opportunity to increase the value and methodological rigor.180 Although many of the 
studies in paper II were stated as pilot trials, few if any reported feasibility outcomes, 
nor have they progressed to large scale RCTs. All of them however reported effect, which 
given the small sample sizes, it can be questioned whether they were powered to do so. 
Properly piloting a trial design ahead of investing in a large RCT is ultimately also a 
question of avoiding research waste.181 If a design is found not to be feasible, then 
researchers avoid wasting costs and resources, and more importantly participants avoid 
wasting their time and commitment. The pilot trial in this thesis (paper III) primarily 
served to improve the design of the EXPANd trial,116 but the transparent reporting 
allows for other researchers to replicate feasible elements and avoid disadvantageous 
ones. As mentioned previously, we need RCTs with data aggregable for meta-analyzing 
in order to move this body or research forward and to be able to provide guidance to 
clinicians as to how rehabilitation can be tailored for PwPD.  
6.2 ETHICAL CONSIDERATIONS 
Ethical considerations in research pertains to three key concepts: autonomy, beneficence 
and justice. 182  
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In interview studies, there are a several important aspects of these concepts to consider. 
Regarding autonomy in the paper I, each participant signed a written informed consent. 
Participants were excluded if they scored <21 on MoCA in order to minimize the risk of 
including individuals with compromised autonomy. Beneficence pertains to 
confidentiality and the importance of keeping the identities of participants 
anonymous.182 I have kept this in mind during manuscript writing, in order to make 
sure that it will not be possible to reveal the identity of the participants from either the 
quotations, the descriptive table or any other part of the paper. The last key concept, 
justice, concerns equal share and fairness, and in qualitative research more specifically 
the need to recognize the vulnerability of the participants.182 The roles as  interviewer 
and interviewee can cause a power imbalance, and these differentials needs to be 
acknowledged.183 With respect to this, interviews were conducted at a time and location 
of the participants’ choice in order for them to feel as comfortable as possible.  
When conducting a systematic review, it is of equal importance to keep the ethical 
considerations in mind. As Vergnes and colleagues points out, there is a theoretical 
possibility that reviews and meta-analysis publish original research that does not 
respect fundamental ethical principles. 184 Since the Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA) checklist does not include any item 
for ethical consideration, it is of great importance for review authors to include a 
summarizing discussion about ethics in the articles included 185. All studies included in 
the systematic review, paper II, had been approved by their respective local ethics 
committees. However, according to the declaration of Helsinki, human subjects should 
be informed of the aims, methods et cetera, of the paper. Since we have performed a 
meta-analysis, the aim of our review was not the same as the authors of each clinical 
trial, which means that subjects signed consent to the original study without knowing 
the aim of our paper.  
Due to logistical shortcomings and the handling process, several of the blood samples 
that where drawn from participants in order to assess levels of BDNF, were lost. This 
was not only a logistical problem that needed to be addressed before the definitive RCT, 
but also an ethical issue. In order to minimize the risk of this happening again, we 
therefore organized a more stringent handling of the blood samples for the RCT 
whereby a core facility was engaged in the project. All blood samples for the RCT have 
thereby been stored safely, as well as collected and preprocessed in the same manner. 
There were ethical issues to consider with respect to the MRI environment. Each patient 
was informed of potential hazards and assessed carefully with respect to their risk in 
the MRI environment. When there was any uncertainty, a clinical radiologist was 
consulted. The most dangerous risks are from ferromagnetic objects and from 
implanted electromechanical devices, such as pacemakers or deep brain stimulators 
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that cannot function in the magnetic field. Considering possible claustrophobia during 
the MRI-scan, every potential participant was instructed to tell us immediately if this 
was the case by pressing the alarm button. Following the scan, a specialist in 
neuroradiology and a neurologist screened all subjects for anomalies of pathological 
significance and each medically responsible in the respective project was contacted 
when action was needed. All participants were informed in advance that their images 
would be screened and that they would be informed in case of pathologies. 
6.3 METHODOLOGICAL CONSIDERATIONS 
6.3.1 Mixed methods 
In the increasingly complex, dynamic and interdisciplinary world of research, we need 
to be able to complement methods with one another. Communication and 
collaboration between researchers in different disciplines has the possibility of 
providing exceptional research, and a prerequisite to this is understanding methods 
used by the other.186 This thesis utilizes methodological plurality in that it includes both 
qualitative and quantitative inquiries of various designs. I have used interview data to 
explore perceptions of balance and gait as experienced by PwPD and complemented 
this with performance data from a cross-sectional investigation of these symptoms. I 
have assessed the feasibility of exploring exercise induced neuroplasticity in a Swedish 
setting and complemented it by systematically reviewing all available evidence for 
neuroplastic training effect in various settings worldwide. Since the data from the 
different papers has not been aggregated, the thesis as a whole can therefore be 
considered as a having a mixed methods approach with a segregated model.187 Using 
qualitative and quantitative data together may provide more complete knowledge,186 
and could therefore be considered as a primary methodological strength of this thesis.  
6.3.2 Trustworthiness – Paper I 
The credibility of a qualitative study relates to how well the collected data and the 
analytic process addresses the intended focus.188 As the focus in paper I was on the 
concept of balance, and how people with PD perceive this, we purposefully strived to 
include participants who we thought would have different perspectives and viewpoints 
concerning balance. One example is how we strategically included people without 
experience of organized exercise, a group previously underrepresented in research. This, 
along with a diversity in demographics, self-reported health and physical function, 
constituted our maximum variation sampling.110 Another way of ensuring credibility of 
the findings in paper I was the use of investigator triangulation during the analytic 
process.189 Initial meaning unit identification was done by myself, and then validated by 
two additional authors (BL and KSR). Coding and interpretation were performed 
through discussions with all authors during several team debriefing meetings. Involving 
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different researchers in the analytic process is also a way to address dependability. 
Dependability relates to whether the research findings are consistent and repeatable. 
The interviews in this thesis were conducted within a period of five months during 
which only minor changes were made to the order of the questions. It is however 
possible, if not probable, that mine and the other authors’ backgrounds as physical 
therapists may have influenced the analytic process and interpretation of the findings.   
In order to increase conformability, we adhered to a transparent reporting in the 
published article whereby a sample of questions from the interview guide was provided, 
as well as examples of the analytic process from meaning units to subthemes. 
Throughout the results section we also provided citations that we thought best mirrored 
the content of each theme. 
In qualitative research, the findings are not meant to be thought of as facts, but rather 
as descriptions, perceptions or theories that are applicable within a specified setting.190 
It is the responsibility of the author(s) to provide enough detail on  both the participants 
and the research process so that the reader can make a “transferability judgment”, i.e. 
assess whether the findings are transferable to his or her own setting. With this in mind 
we provided rich descriptions of the participants, not only with regards to demographic 
information, but also pertaining to self-reported measures on health as well as 
performance measures of gait, balance and motor function. We also described details 
on recruitment, setting and the interview situation.  
Preferably, the subjective experience that interviewees describe is reflected upon and 
interpreted by the researcher using different theories and philosophies. This way of 
perceiving and interpreting the same phenomena from different angles increases 
objectivity, also referred to as reflexivity.191 In paper I we have used various theories, 
mainly from the psychological research field, in the interpretive process.  Our use of 
theories such as the Common sense model of self-regulation,163 or Locus of control,161  
enabled us to relate the described experiences in a broader context. 
6.3.3 Experimental validity – Papers II-IV 
6.3.3.1 Introduction to the concepts 
The research literature abounds with definitions and descriptions on the concept of 
validity. The following paragraphs will focus on experimental validity, and specifically 
on internal and external validity. Internal validity concerns the degree to which the 
methods and design of a study allows the researcher to conclude that there is a causal 
relationship between treatment and outcome. In a study with poor internal validity, the 
likelihood is high that the results are attributable to factors other than treatment.192 
External validity instead relates to within what context the findings from a study can be 
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applied, and more specifically to generalizability and applicability. Generalizability 
concerns whether the findings can be extended to the population from which the 
sample is drawn, whereas applicability concerns whether inferences drawn from the 
study sample can be extended to specific patients of any population.193  
6.3.3.2 Paper II 
Synthetic knowledge acquired from systematic reviews is theoretically of the highest 
form, at least in terms of achieving results of high internal validity.194 We did however 
not exclude papers based on high risk of bias or poor quality, hence the synthesized 
knowledge in paper II includes results from studies of which some had poor internal 
validity. While this may be considered a limitation, as of present, there are too few high-
quality studies published in this area to allow for credible conclusions. Therefore, the 
broader inclusion approach used in this paper can be considered to reveal valuable 
information with regards to this novel treatment outcome. We chose to include all types 
of evaluative methods for neuroplasticity and various types of physical exercise 
interventions (i.e. at least two training sessions). All decisions on inclusion, both at 
title/abstract stage, and at full-text stage, were done by two authors blinded to each 
other’s decisions. Quality assessment was done by one author (HJ), and decisions were 
checked by a second author (EF).  
In systematic reviews, there is a lack of reporting on external validity and whether 
results can be generalized or applied to other populations and settings.195 This is 
unfortunate as it makes clinical decision making based on the results problematic. 
During the write-up of paper II, several issues were encountered that rendered 
statements and conclusions on external validity difficult. Overall, the information on 
the population from which the sample was drawn in the different studies was 
incomplete or inconsistent. There was even a lack of information on the studied sample, 
especially when authors had analyzed a subgroup of a larger study. Paper II is not 
intended to support clinical decision making per se, but rather for use by researchers 
interested in evaluating neuroplastic effects of training. As this research area is still in 
its infancy, future meta analytic results, preferably based on larger RCT’s will be better 
equipped to make clinical recommendations. 
6.3.3.3 Paper III 
One of the primary purposes of conducting feasibility studies is to reduce the threats to 
internal validity for the definitive trial.196 In the pursuit of this we monitored the 
proposed design in order to detect when and where possible risks of bias may occur. 
We used a random assignment to parallel groups which should control for many of the 
threats to internal validity, except experimental mortality (attrition).192 We had one 
drop-out from the control group, but this was unrelated to PD or to the intervention. 
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Given the vulnerability of small sample sizes, the drop-out may however have skewed 
the control group results in a false-positive direction. A diagnosis of idiopathic PD was 
verified either through confirmation from the participant’s neurologist, or through 
medical journal transcripts in order to reduce the risk of misclassification bias. 
Participants performance on balance, gait and motor function was assessed by the same 
evaluator at both pre- and posttests. By doing so we minimized the risk of observer 
changes being more influential on the study results than the true treatment effect.192 
Another aspect with regard to the assessments is that all participants were assessed in 
their ON medication state and at the same time of day at pre and post-test sessions. 
This is important as PwPD may suffer from motor fluctuations leading to big differences 
in performance while in an optimally medicated state and when the medication is 
starting to wear off.27  During clinical testing of balance and gait, the order of the tests 
was also randomized in order to control for fatigue.  
In pilot and feasibility trials, the main focus in regard to external validity lies in 
providing enough information for the reader to judge whether methods and findings 
can be applied to a future trial or other studies.114 Although the setup of paper III may 
not be replicable in its entirety in other settings or populations, large parts of our 
feasibility results may be of use to other research groups planning similar projects. We 
had a recruitment rate of 31% (13 out of 42 people who initially reported interest). Half 
(13 people) of those excluded during initial telephone screening were so based on 
reasons related to the MRI environment (incompatible implants and/or 
claustrophobia). We did not perform any analysis of those who were excluded before 
the eligibility assessment, other than taking note of reason for exclusion and sex. A more 
thorough collection of background data on these people could have provided useful 
information in regard to the population from which our sample was drawn and 
improved our ability to generalize the results. Even though the sample size of paper III 
does not allow for generalization of effect to routine clinical practice, it is still worth 
discussing inclusion criteria. In papers III-IV, we included people with mild to moderate 
PD who were 60 years of age or older, similar to previous HiBalance evaluations.82, 85 
Because of the MRI environment, we did however exclude people with duodopa pump 
or deep brain stimulation, a factor that may have led to inclusion of a somewhat 
healthier sample. These treatments are however usually offered as adjunct therapy 
options during the advanced stages of the disease.27 Had these participants not been 
excluded already during the telephone screening, there is therefore a probability that 
they had been excluded during the eligibility assessment.  
6.3.3.4 Paper IV 
One of the major threats to internal validity in paper IV is the absence of a control 
group. Without a group of healthy controls, we cannot with certainty say that our 
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results are unique to PwPD. Further, since exposure and outcome are measured at the 
same time, causality is often unclear in cross-sectional studies.   
As almost identical inclusion and exclusion criteria were used for paper III and paper 
IV, several of the issues pertaining to generalizability in paper III is also true for paper 
IV. In addition, for the secondary purposes in paper IV we excluded almost a third of 
the sample as they could not with certainty be classified as either PD MCI or PD non-
MCI. This is a falsification of reality as this group very much exist in the real world. In 
reducing the risk of misclassification bias we instead compromised our ability to 
generalize the results, resulting in a trade-off  between internal and external validity.197  
6.4 CLINICAL IMPLICATIONS 
The results of the interviews imply that a main key when choosing assessment method 
and training intervention, as well as motivating our patients lies in posing the right 
questions. We need to understand how people with PD make sense of balance and gait 
impairments and to what extent they believe that change is within their own control. 
We also need to be aware of the extent that a person uses cognitive or physical 
adaptations to influence balance in everyday life, as this will give us an indication as 
how to best challenge them during training.  
As previously established, when evaluating DT effects during walking, we need to 
consider changes in performance on both gait and the secondary task. With both these 
pieces, we as clinicians can lay the puzzle to understand how a patient is affected when 
performing two tasks and then help translate it to real life contexts.  
People with PD MCI as compared to PD non-MCI may have a different pattern of DT 
interference, as well as a different type of prioritization between tasks. This can have 
clinical implications since using a posture-second strategy may place people with PD 
MCI at greater risk for falls. Performing a neuropsychological test battery may therefore 
help guide rehabilitation and assessment of locomotor symptoms.  
Gait speed is easily assessed in the clinic and should continue to be a main outcome in 
the PD population. However, with accelerometers and other body-worn sensors for step 
detection being increasingly affordable and assessable, clinicians can and should when 
possible also evaluate other aspects of the gait cycle, especially during DT gait 





6.5 FUTURE RESEARCH 
Many of the findings presented as well as each methodological deficiency noted in this 
thesis represents an opportunity for improvement and future research.  
There is still a paucity of qualitative research in PD. We should aim to understand how 
PwPD make sense of their plethora of symptoms, not just balance, if we wish to improve 
communication and motivational strategies for rehabilitation. Different qualitative 
efforts may help explore how symptoms are experienced, how this experience changes 
over time and to what extent they feel that improving their symptoms lies within their 
own control.  
Despite efforts in this thesis, and by other research groups, much of the variance in DT 
effect is still unexplained for. More work is needed here to elucidate which factors can 
predict the ability to DT. Future studies can also help confirm or refute whether there 
is in fact a difference in task prioritization between people with PD MCI compared to 
PD non-MCI. Larger sample will also allow the investigation of whether there are 
differences across different cognitive profiles. 
The reliability of using DT effect variables to evaluate training effects are still uncertain 
and need more investigation. 
Research into exercise-induced neuroplasticity is still in its infancy, and much more 
work is needed before we can conclude which type of training and which dose is optimal 
for PwPD. Given the high costs of this type of research, along with a great need for 
adequately powered studies, collaborative efforts between research groups would help 
move this body of research forward. Researchers should strive to collect data using 
comparable interventions and aggregable outcomes. Transparent reporting of feasible 
elements, and perhaps even more important - disadvantageous ones, should be made 













Among people with Parkinson’s disease, balance was perceived as a multilayered 
concept entailing both bodily equilibrium and the interplay between mind and body. 
The meaning of balance was intertwined with concepts of control, and whether one 
could control the body in everyday life. Participants described how they exerted 
influence over balance by directing focus and attention to the task at hand during 
balance-challenging situations. Exercise was seen by some as a means to improve 
balance, whereas others with previously bad experiences of exercise did not believe that 
they had any control over the progression of their balance impairments. Regardless of 
whether participants believed in their own ability to affect balance, several expressed 
how they had developed a psychological resilience to face the challenges of impaired 
balance.   
Although a majority of studies published on PD indicate that various types of exercise 
may have the possibility to induce positive neuroplastic changes in the human brain, 
the concerted evidence as of today is very low. More high-quality randomized 
controlled trials, using scientifically sound methodology and transparent reporting are 
needed in order to drive this research field forward.  
Our proposed design for a future randomized controlled trial investigating the effects 
of the HiBalance program on markers of neuroplasticity in PwPD proved feasible and 
acceptable. Overall participant acceptability of all three pre- and post-assessment 
sessions, as well as both the HiBalance and HiCommunication interventions were good 
as shown via follow-up questionnaires, attendance rates and home-exercise diaries. 
Some elements of the design will however need modifications, including strengthening 
of the blinding procedures, introduction of an expectancy questionnaire, improved 
logistical handling of the blood samples, and changes to both MRI paradigm and the 
DT gait assessment.  
When walking while simultaneously performing a cognitive task, our sample of people 
with mild to moderate PD exhibited DT costs across all domains of gait except 
asymmetry. They also increased their RTs and SDRTs on the cognitive task, whereas a 
high accuracy was maintained from single to DT performance. Subgroup analysis 
revealed that people with PD MCI used a posture-second strategy as opposed to the PD 
non-MCI group who tended to use a posture-first strategy. These findings provide 
preliminary evidence to suggest that DT training and assessment should be planned 
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